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CHAPTER I 
 
INTRODUCTION 
 
1.1 Nuclear magnetism 
 
     Magnetic resonance spectroscopy (MRS) is a non-invasive technique that can be used 
to quantify various chemicals and identify molecular structures.  MRS relies on the 
existence of a net magnetic moment of nuclei with either odd protons or neutrons.  A 
nucleus with spin I can have (2I + 1) energy levels that are quantized and separated by 
ΔE. 
€ 
ΔE =
µBo
I
     (1.1) 
 So for a spin ½ there are two possible states: +½ and -½. In the presence of an external 
magnetic field, the magnetic dipole moment (µ), if oriented at an angle to the applied 
field, experiences torque (τ) and precesses about the applied field.   
   
€ 
τ = µX B  (1.2) 
The interaction Hamiltonian of the spin with applied magnetic field is given by: 
   
€ 
HZ
I = −γI⋅ (1−σ I )⋅ B0  (1.3) 
This is referred to as the Zeeman Hamiltonian and is frequently expressed in angular 
frequency units (divide through by ).  is the gyromagnetic ratio which is unique to 
different nuclei, for Hydrogen,  = 42.6MHz/Tesla.  The  term in each of these 
expressions refers to the chemical shift of the spin I.   
Chemical shifts are often described as being more or less shielded or upfield and 
downfield, respectively. Shielding is theoretically measured with respect to a bare 
nucleus (a difficult circumstance to create) and simply means that the magnetic field, B0, 
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is effectively reduced at the nucleus due to the interaction of the electrons surrounding 
the nucleus.  The chemical shifts and spin-spin couplings (J-couplings) of different 
chemicals give rise to a spectrum that is characteristic of that particular chemical. J-
couplings are the couplings between two spins that are mediated by the bonding 
electrons. Spectra of specific metabolites can be used to obtain information on chemical 
shifts and j-couplings as well as the chemical structure of the metabolites.  The concept 
behind the generation of the spectrum in the context of one spin and two weakly coupled 
spin systems are discussed below. 
      The eigenvalue equations for the single-spin Hamiltonian (Eq. 1.3) are: 
 
€ 
HZ
I + − = ±
ω I
2
⎛ 
⎝ 
⎜ 
⎞ 
⎠ 
⎟ + −  (1.4) 
where   
€ 
ω I = ω0(1−σ I )  and is called the Larmor frequency, the precession frequency of 
the spin under the influence of a static magnetic field, B0, and  is the natural 
precession frequency in the absence of chemical shielding.  In these expressions,  and 
 refer to states parallel and anti-parallel to  
€ 
B0 ⋅ z , respectively, and it follows that (with 
this convention) the  state is lower in energy than the  state. The energy associated 
with the transition between the two states is: 
   
€ 
ΔE± = E− − E+( ) = ω0(1−σ I ) = ω I  (1.5) 
This energy is simply the interaction energy of the spin with the static field, where the 
field has been scaled by the chemical shift.   
      The Hamiltonian for a weakly coupled 2 spin system in the eigenbasis is given by: 
   
€ 
H = HZ
I + HZ
S + HJ
IS, (1.6) 
 3 
 where    
€ 
HJ
IS = JIIZ .ISZ  
and the corresponding eigenvalue equations are:  
 
  
€ 
HZ +I ;+S = (− 12 ω I +ωS( ) + J / 4) +I;+S
HZ +I ;−S = (− 12 ω I −ωS( ) − J / 4) +I;−S
HZ −I ;+S = (+ 12 ω I −ωS( ) − J / 4) −I;+S
HZ −I ;−S = (+ 12 ω I +ωS( ) + J / 4) −I;−S
 (1.7) 
The transition probabilities and the corresponding transition energies are: 
 
  
€ 
|< +I ;+S | J
+ | −I;+S >|
2 = 1⎯ → ⎯ ΔE = −ω I + J / 2
|< +I ;+S | J
+ | +I;−S >|
2 = 1⎯ → ⎯ ΔE = −ωS + J / 2
|< −I ;+S | J
+ | −I;−S >|
2 = 1⎯ → ⎯ ΔE = −ωS − J / 2
|< +I ;−S | J
+ | −I;−S >|
2 = 1⎯ → ⎯ ΔE = −ω I − J / 2
 (1.8) 
 
Figure 1.1. Spectral lines generated from simulation of weakly coupled 2-spin system with 
the chemical shifts of 2ppm and 4ppm and J-coupling of 6Hz. 
 
The generalized Hamiltonian for the spin systems are: 
 
  
€ 
HZ
i = γ iB0 1−σ i( )I = ω i Iiz
and
HJ
ij = JIi ⋅ I j
 (1.9) 
where  represents the individual spin Hamiltonian and  represents the J-coupling 
Hamiltonian.  As we can see from Eq. 1.9, as the number of spins increase, the  
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Hamiltonian and hence the calculation of the eigenvalues becomes significantly 
complicated.   
 
1.2 Effect of radio frequency (RF) field on the spin in magnetic field 
 
      When an RF pulse is applied with the correct frequency and bandwidth to affect the 
desired spin, the spin experiences two magnetic fields: the static magnetic field (B0) and 
the oscillating RF field (B1) from the excitation coil.  The equations governing the spin 
dynamics in the presence of these two fields in a frame that is rotating at a frequency ω 
are given by (1)  
   
€ 
Beff = (B0 −ω / γ )
2 + B1
2  (1.10) 
and the effective Hamiltonian when B1 is along x-axis is given by: 
 
€ 
Heff = HZ +γB1Ix  (1.11) 
     The RF field is several orders of magnitude smaller than the static field but as seen     
from Eq. 1.12, when B1 is on resonance, the spin will precess about the applied field.    
The flip angle as a result of the B1 is , where t is the duration of the applied field.  The 
effect of the j-coupling on the spins can be understood by using the following 
commutation relations (1). 
 
€ 
2ˆ I 1z ˆ I 2z, ˆ I 1x[ ] = i2ˆ I 1y ˆ I 2z
2ˆ I 1z ˆ I 2z, ˆ I 2x[ ] = i2ˆ I 1z ˆ I 2y
2ˆ I 1x ˆ I 2z, ˆ I 1y[ ] = i2ˆ I 1z ˆ I 2z
2ˆ I 1z ˆ I 2x, ˆ I 2y[ ] = i2ˆ I 1z ˆ I 2z
 (1.12)  
The knowledge of these transformations and the resulting operators has been used to 
devise pulse sequences to maximize the signal from various spin systems. 
€ 
Ix
^
, 
€ 
Iy
^
 and 
€ 
Iz
^
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are the angular momentum operators. The product operator analysis of some of the pulse 
sequences like PRESS and MEGA-PRESS are shown below. 
 
1.3 Relaxation processes  
 
      Longitudinal relaxation or spin-lattice relaxation is the recovery of the component of 
magnetization along the axis of the static field after 90o pulse, usually denoted along z-
direction (Mz) and is characterized by the longitudinal relaxation rate (T1).   
   
€ 
Mz (t) = M0(1− e
− t /T1 ) (1.13) 
 
Figure 1.2. Recovery of longitudinal magnetization following 90 degree r.f. pulse. 
 
       Transverse relaxation or spin-spin relaxation is the loss of magnetization along the 
axis perpendicular to the static field (x and y axes) and is characterized by the transverse 
relaxation rate (T2).  Transverse relaxation occurs due to the loss of phase coherence of 
the spins in the x-y plane due to the fluctuations in the local magnetic fields (dipolar 
interactions) and hence, the effective magnetic field experienced by the spins.  Transverse 
relaxation can be observed as an exponential decay in the signal.  
 6 
   
€ 
Mxy = M0e
−t /T2  (1.14) 
 
Figure 1.3. Exponential decay of the transverse magnetic field due to T2 relaxation. 
 
1.4 Localization 
 
     Localization in NMR spectroscopy is achieved by applying a sequence of frequency-
selective RF pulses in the presence of a B0 field gradient. The thickness of the region of 
interest along each direction is controlled by the bandwidth (BW) of the RF pulse and the 
B0 field gradient (Gi) and follows the following relationship:  
 
€ 
x =
BW
γGx
 (1.15) 
where x is the size of the voxel in x-axis, BW is the bandwidth of the RF pulse and 
€ 
Gx  is 
the slope of the gradient applied in the direction of localization, x-axis in this case.  When 
the frequency selective RF pulse is applied in conjunction with linear B0 field gradient to 
only affect a slice of a volume it is called a slice-selective pulse.  Single voxel 
localization is accomplished by the application of these slice-selective pulses in three 
directions in sequence such that only spins in a limited volume experience the intended 
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rotation of the spins resulting in the observable signal generation from that particular 
volume.  
     The difference in Larmor frequency ω0 that aids in the discrimination of metabolites 
leads to the spatial displacement Δx of the localized volume between different 
metabolites: 
 
€ 
Δx =
Δω
BWrf
x  (1.16) 
where 
€ 
x  is the size of the voxel, 
€ 
Δω  is the difference in chemical shift between to 
protons, 
€ 
BWrf  is the bandwidth of the RF pulse, 
€ 
Δx  is the chemical shift displacement in 
voxel direction (2). 
 
1.5 Pulse sequences 
 
     Three dimensional localization pulse sequences like Point Resolved Spectroscopy 
(PRESS) and Stimulated-echo Acquisition Mode (STEAM) are two of the widely 
available pulse sequences on standard human MRI scanners.  
PRESS 
 
      PRESS sequence is a double spin echo sequence that consists of an initial 90o pulse 
that tips the net magnetization in the transverse plane, followed by two 180o pulses to 
refocus chemical shift evolution and free induction decay signal acquired at the end of the 
echo time.  The pulse-timing diagram for PRESS pulse sequence is given in Figure 1.4. 
The application of the initial 90o excitation pulse tips the net magnetization in the 
transverse plane and the spins undergo chemical shift and j-coupling evolution for time 
TE1 until the application of 180o pulse, which inverts the net magnetization and the 
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chemical shift evolution begin to refocus with a spin echo being formed after the delay 
TE1 where the chemical shift evolution is completely refocused.  The spins continue to 
evolve during the first TE2 delay until the second 180o pulse refocuses the chemical shift 
evolution that occurred during the TE2 delay with the second spin echo being formed 
after duration TE2 after the second 180o pulse.  For an IS spin system, the resulting 
product operator is given below: 
 
€ 
Iz = −Iy cos{πJTE}+ 2IxSz sin{πJTE}
Sz = −Sy cos{πJTE}+ 2IzSx sin{πJTE}
  (1.17) 
For the given pulse timings, chemical shift evolution is refocused at the end of the echo-
time as we can see from the resulting terms in the product operator. 
       
Figure 1.4. Timing diagram of PRESS pulse sequence with an echo-time of TE 
     These pulse sequences can be modified by addition of pulses to acquire data from 
specific spin systems that are otherwise difficult to detect and quantify.  One example of 
such modified pulse sequence is MEGA-PRESS sequence, which consists of two 
additional frequency-selective pulses.  
 
MEGA-PRESS 
 
     MEGA-PRESS is a frequency selective refocusing technique that was proposed by 
Mescher et al in 1998 as a way to simultaneously suppress water and perform spectral 
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editing.  MEGA-PRESS is widely used to acquire J-difference spectra for metabolites 
like γ-Aminobutyric Acid (GABA) (3, 4) and Glutathione (GSH) (5), which, are difficult 
to quantify due to the presence of overlapping resonances on spectra acquired without 
any editing (3). MEGA-PRESS consists of two additional frequency selective pulses the 
first of which is placed between the two refocusing pulses of PRESS sequence and the 
second is placed after the second refocusing pulse. The second modification in the 
MEGA-PRESS sequence from PRESS sequence is the rearrangement of the second set of 
crusher gradients.  These gradients are rearranged to dephase only those spins that 
experience the additional refocusing pulses. 
 
 
(Waddell et al 2007)  
Figure 1.5. MEGA-PRESS J-difference editing pulse sequences. 
 
Editing pulse on: 
 (1.18) 
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     We can see from the resulting product operator that as long as the timing below is 
satisfied, the spins coupled to the spins refocused by the additional frequency selective 
pulses are independent of time and purely absorptive as long as: 
€ 
t1 + t2 − t3 − t4 + t5 = 0 . 
Also, since 
€ 
t1 + t2 + t5 = t3 + t4  from PRESS sequence, and it follows that: 
 
€ 
t1 = shortest
t2 =
TE
4
t4 =
TE
4
t5 =
TE
2
− t1 − t2
t3 =
TE
2
− t4 =
TE
4
 (1.19) 
 
Editing pulse off: 
      
€ 
Iz →−Iy cos{πJIS (t1 + t2 + t3 + t4 + t5)}+ 2IxSz sin{πJIS (t1 + t2 + t3 + t4 + t5)}
Sz →−Sy cos{πJIS (t1 + t2 + t3 + t4 + t5) + 2IzSx sin{πJIS (t1 + t2 + t3 + t4 + t5)}
 (1.20) 
Resulting difference observable operators (on – off) after using trigonometric identity for 
cosine: 
€ 
2Iy{sin{πJIS (t1 + t2 + t5)}sin{πJIS (t3 + t4 )}+ 2Sy{sin{πJIS (t1 + t2 + t5)}sin{πJIS (t3 + t4 )} (1.21) 
An example of spectra acquired during on and off acquisitions along with the j-difference 
spectra is shown in figure 1.6.  
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Figure 1.6. Simulated spectra for weakly coupled 2 spin system for MEGA-PRESS with 
editing pulse applied at 1.9ppm (top), editing pulse off (middle) and the 
difference spectrum (bottom). 
 
1.6 Practical considerations 
 
Signal-to-noise 
 
     The signal-to-noise ratio (SNR) of metabolites is directly proportional to the voxel 
size, static magnetic field (B0), the square root of the number of acquisitions and the 
concentration of the metabolite of interest. The concentration of water in the brain is 
much higher than the concentration of metabolites (50M vs. 1-15mM) such that 
metabolite measurements cannot be made without either suppressing the water signal 
during data acquisition or using singular value decomposition (SVD) to subtract the water 
signal during post-processing phase. The low concentration (mM levels) of metabolites in 
the human brain the signal-to-noise ratio (SNR) from a single shot is not enough to make 
metabolite concentration measurement. Therefore, a number of transients are acquired 
and averaged together in order to achieve high enough SNR to quantify concentrations.    
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Baseline 
 
     One of the issues that need to be handled carefully for accurate quantification is 
baseline fluctuation.  The origin of baseline is believed to come from macromolecules 
and residual signal from water.  The residual signal from water can be approximated as 
an exponential decay and the baseline contribution from macromolecules appear as a set 
of broad peaks due to short T2 relaxation of the macromolecules.  The spectral 
contribution from macromolecules have been studied by various groups (6, 7) among 
which the results obtained by Behar’s paper is likely one of the most detailed and careful 
studies conducted to characterize the chemical shifts and j-couplings on macromolecule 
spectra.  Mishandling of the baseline fluctuations can result in the incorrect quantification 
of metabolites.  Hence, some quantification tools include a semi-parametric fitting of the 
baseline by incorporating prior knowledge of the baseline contribution from residual 
water signal and macromolecule spectrum. One of the approaches to approximate the 
baseline has been to acquire ‘metabolite-nulled’ spectrum to be used as part of the basis 
set during metabolite quantification.  However, due to the differences in longitudinal 
relaxation rates of the metabolites, acquisition of a truly metabolite-nulled spectrum is 
difficult and the acquired spectrum is contaminated by residual peaks from the 
metabolites with different inversion-recovery rates during spectra acquisition causing 
further error in the analysis. A way to circumvent the issue is to use pulse-sequences that 
allow the use of non-parametric methods like MEGA-PRESS. MEGA-PRESS is widely 
used for making GABA measurements by selectively refocusing the coupled resonance 
of interest on alternate scans and subtracting the two scans.  This effectively removes the 
baseline from the resulting spectra and results in a more manageable spectrum to analyze. 
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B0 inhomogeniety 
 
     The increase in the strength of the static magnetic field has the added benefit of 
increased SNR and spectral resolution, however, increase in B0 also bring with it some 
challenges. A homogeneous static magnetic field is one of the requirements of acquiring 
spectrum of good quality and as we go to higher fields it becomes harder to achieve 
reducing our ability to discriminate between different resonances. B0 homogeniety 
influences the Larmor frequency of the protons hence, an inhomogeneous static magnetic 
field causes a distribution of Larmor frequency from the same metabolite.  This, in turn, 
causes the pulses applied to effect the signal coming from a particular metabolite to be 
effected differently by the same pulse and ultimately cause incoherent signal averaging as 
well as result in signal that deviate from the expectation from prior knowledge for signal 
generated from a homogeneous field. The preparation phase of the scan includes a 
process to homogenize the static magnetic field and is called shimming. 
 
B1 inhomogeniety  
 
     One of the challenges in acquiring high quality spectra arises from B1 inhomogeneity. 
The attenuation and interference of radio waves and absorption of radiation in the tissue 
increases as we go to higher fields. The frequency of the transmitted RF radiation needs 
with increase in B0 leading to an increase in the degree of RF attenuation in a dielectric 
medium such as the human body. Also, at the emerging field strength of 7 Tesla, the RF 
wavelengths decrease to ~ 10 cm, roughly the dimension of the human head.  As the 
dimension of the RF wavelengths in the dielectric medium approach the sample 
dimension, standing waves are generated in the sample causing spatially varying B1 field 
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being experienced across the sample.  This generates problems with the depth of RF 
penetration of the body along with varying RF amplitude delivery across the selected 
volume (8). The methods used to reduce B1 inhomogeniety are the use of B1 insensitive 
pulses and multi-transmit coil. 
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CHAPTER II 
 
 
SIMULATION AND QUANTIFICATION OF NEUROTRANSMITTER 
MEASUREMENTS BY MRS 
 
2.1 Simulated basis set 
 
In vivo MRS of the brain is aimed at acquiring information about various 
metabolites, their intermediates, and their levels in normal subjects as well as subjects 
with various disorders.  Quantitative measurement of the concentrations of metabolites 
can be used to establish the normal levels in healthy subjects and to study the changes 
that occur in diseases (9-12). MRS may also be used to investigate the energetic basis of 
brain activity studying the changes in metabolic profile during regional activation (13, 
14) and modeling these changes also demands precise quantification of metabolites. 
Various quantification techniques are used to measure the metabolite concentrations from 
spectra obtained in vivo, most of which rely on prior knowledge.  
The spectra of individual compounds may be acquired from in vitro experiments 
or predicted from simulation and these form a basis set by which experimental spectra 
can be fitted.  Acquisition of individual in vitro metabolite spectra for use as a basis set 
demands highly controlled parameters to avoid contamination of solutions and ensure 
temperature and pH that mimic in vivo conditions.  It also requires careful monitoring of 
the integrity of the solutions prior to acquisition of spectra since the solutions can degrade 
over time.  It can also be highly tedious to acquire in vitro spectra for different echo times 
and pulse sequences for all the different metabolites of interest at different static 
magnetic field strengths.   
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Use of simulated spectra, on the other hand, can be a much quicker and more 
reliable approach if the chemical shifts and J-coupling constants of the metabolites are 
known (15). The information available on the spin systems of metabolites of interest can 
be used to study the effects of pulse sequence and echo-times on the resulting spectra 
using numerical simulations.  Packages like JMRUI and GAMMA libraries in C++ can 
be used to simulate spectra for different pulse sequences and to predict complex spectra 
for mixtures of different metabolites (16, 17).  Apart from the efficiency of basis set 
generation, simulated basis set have the added benefit of having narrow linewidths and 
having infinite SNR since simulated spectra are free of noise.  Hence, simulated basis sets 
allow for more precise and accurate quantification and having an accurate basis set is key 
to accurate quantification of metabolites. 
Efficient generation of simulated basis set for quantification of metabolites 
involves writing programs to perform density matrix simulations of the evolution of spins 
as a function of applied RF pulses, normalizing the simulated spectra and formatting the 
normalized spectra for use with the quantification tool of choice, which in our case is 
LCModel.  This chapter details the basis set generation process we have built and used 
for generating basis sets for analyzing the experimental data sets and for optimizing the 
metabolite detection echo-time as part of this thesis. 
 
2.2 Density Matrix Simulations 
 
GAMMA libraries, written in C++, aid in performing density matrix calculations 
and can be used to perform density matrix simulations using ideal or real pulses for 
individual metabolites for a specified pulse sequence (17). GAMMA libraries consist of 
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sub-routines for performing individual spin and spin system operations and can be used 
to design and run full density matrix simulations for any pulse sequence. GAMMA 
libraries require information such as nucleus, chemical shift, j-couplings of the spin 
system of interest, and static magnetic field strength (B0) as inputs.  C++ programs can be 
written to specify the parameters to be used for simulations such as pulse sequence 
design, pulse types and echo-time. An example of spin system specification for a system 
with 2 spins with a J-coupling of 7 Hz is shown in Appendix A.1. 
Once the spin information is passed to the program, the density matrix for a 
system in equilibrium is generated. As the system is perturbed by the RF-pulses, the 
density matrix evolves under the effect of the perturbation.  
€ 
σ
^
(t + t0) = e
−i H
^
tσ(t0)e
i H
^
t
 
where 
€ 
σ
^
(t + t0) is the density matrix after evolution under the influence of acting 
Hamiltonian 
€ 
H
^
 and 
€ 
H
^
= H 0+ Hrf . 
 Spin simulations for systems with larger numbers of spins require large matrix 
sizes to be computed and the density matrix simulations become significantly slower for 
spins with 8 or more spins. In these cases, splitting spin systems into smaller systems 
while grouping coupled spins as one spin system and running density matrix simulations 
has been proven to restore the efficiency.  For metabolites like choline, phosphoryl 
choline and glycerol-phosphocholine that consist of 13, 13 and 18 spins respectively with 
9 spins each that are singlets, splitting the spin systems is an ideal solution. An example 
of a program that illustrates the Point Resolved Spectroscopy (PRESS) sequence with 
ideal pulses is given in Appendix A.2. 
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The GAMMA package also includes sub-routines that facilitate applying real 
pulse shapes to be incorporated in simulations in order to study the effect of RF-field 
strength, pulse shapes and bandwidths in the resulting spectrum. A program that 
illustrates PRESS sequence with real pulses is given in Appendix A.3. An example 
showing close agreement between an experimentally measured in vitro glutamate 
spectrum and a simulated glutamate spectrum is shown in Figure 2.1.   
 
Figure 2.1. In vitro (blue) and simulated (red) glutamate spectra acquired at 3 Tesla with 
PRESS sequence at an echo-time of 73 ms. The simulated spectrum was generated using 
ideal pulses. 
 
2.3 Normalizing the simulated spectrum 
 
The resulting time-domain signals from the GAMMA simulations need to be 
normalized to allow quantitative evaluation of spectra. In the correct representation of the 
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spectrum, the spectra should scale linearly as a function of the number of spins such that 
the area under a singlet peak from 2 spins should be twice that under a singlet peak from 
1 spin. However, the output from GAMMA simulations is scaled according to an 
exponential function based on the number of spins in the spin system and needs to be 
accurately normalized. This issue is addressed by adding a singlet resonance at 15 ppm, 
away from any of the metabolite resonances in the brain, as part of the spin system of 
interest.  The density matrix calculations are performed on the spin systems that include 
the reference peak that is used to correct the phase of the spectrum as the first step after 
the completion of density matrix simulations.  The second step entails correcting for any 
baseline fluctuation in the reference peak, due to the influence of the metabolite 
resonances, by fitting a line between 14 ppm and 16 ppm spectral window and 
subtracting the baseline from the peak.  The third step is calculating the area under the 
reference peak after baseline subtraction and normalizing the area to 1 for all metabolites 
and saving the resulting spectra as .SDAT and .SPAR files.  .SDAT files contain the free 
induction decay signal (FID) and .SPAR files contain the acquisition parameters in the 
format compatible for MRS data from a Philips MR scanner. 
The accuracy of the normalization of the simulated spectra is crucial for the 
spectra to be useful in analyzing experimental data; hence even the slightest baseline 
fluctuation contribution from metabolite resonances far from the reference peak needs to 
be subtracted. The results from quantification of metabolite concentrations will be less 
accurate if analyzed using inaccurately normalized or randomly scaled spectra as prior-
knowledge. 
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2.4 Quantification 
 
Some of the methods for quantifying metabolite concentrations from an 
experimental spectrum include calculating the area under the metabolite peaks or fitting 
the peaks in the spectrum by using a basis set generated using prior-knowledge. 
Measurements of metabolite concentrations by calculating the area under the metabolite 
peaks are feasible in cases where there is a distinct peak from a metabolite without 
contamination from other metabolite resonances and the SNR is adequate.  However, 
several metabolites of interest like glutamate and glutamine suffer from significant 
spectral overlap from other metabolites and from each other.  In these cases, fitting all the 
resonances in the spectral window of interest yields a more reliable measure of 
metabolite concentrations.  Quantification results from MRS are often reported as ratios 
of metabolite with respect to Creatine as the concentration of Creatine is believed to be 
constant (18).  Absolute quantification of metabolites can be performed by comparison of 
metabolite concentrations to known concentrations in samples used as an external 
reference or by using water signal as an internal reference (7). 
 
2.5 LCModel 
 
There are several widely used programs available for analyzing spectra among 
which LCModel is one standard approach used for quantifying metabolite concentrations 
(19). All the experimental data collected for this thesis were quantified using LCModel. 
LCModel uses linear combinations of individual metabolite spectra to fit experimental 
data and minimize the residual noise and output metabolite concentration of the analyzed 
spectrum. LCModel requires individual metabolite spectra to be used as a basis set for a 
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given pulse sequence and echo-time for analysis of experimental spectra.  Figure 2.2 
shows simulated spectra for 17 individual metabolites and the composite spectrum 
generated using a linear combination of the 17 metabolites spectra at echo-time of 73 ms 
for PRESS sequence at 7 Tesla with linewidth of 10 Hz.  The individual metabolite 
spectra were simulated using the procedure outlined in the sections above.   
 
Figure 2.2. Composite spectrum for 7 Tesla generated from 17 individual metabolite 
spectra simulated using ideal pulses in C++ with GAMMA libraries. The spectra were 
simulated for PRESS pulse sequence at an echo-time of 73 ms. 
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2.5.1 Making basis set for LCModel 
 
The individual metabolite spectrum used for analyzing the data for this thesis 
were generated using programs written in C++ using GAMMA libraries as discussed in 
section 2.2 and used in conjunction with LCModel to analyze metabolite concentrations. 
For the generation of LCModel basis set the normalized FID is further saved in a .SDAT, 
.SPAR and .RAW files as per LCModel requirement using custom built programs written 
in MATLAB.   The next step to making a basis set for LCModel is generating a 
makebasis.IN file that consists of information on the metabolites, their FIDs and their 
corresponding concentrations to be used for basis set generation.  An example of a 
makebasis.IN file is shown in Appendix A.4. 
After the generation of basis set for use with LCModel, all data sets with 
acquisition parameters such as the pulse sequence and echo-time matching that of basis 
set can be analyzed using that particular basis set.  A schematic diagram showing the 
basis set generation process and analysis is shown in Figure 2.3. 
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Figure 2.3. Schematic diagram showing the basis set generation and analysis process 
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It is important for the basis set to have all the metabolites that are present in the 
data to be quantified in order to avoid a systematic bias in the quantification results.   
 
2.6 Interpreting LCModel Results 
 
As mentioned in the previous chapter, lack of proper understanding and absence 
of a good model of the baseline in the in vivo data pose key limitations in accurate 
quantification of metabolites concentrations in the human brain.  LCModel uses uniform 
b-spline fits in order to model for the baseline in in vivo MR spectra and is a widely 
accepted practice albeit not a perfect one. LCModel fit uses linewidth and metabolite 
concentration, phase and frequency shift in the data as some of the parameters that are 
regularized during the analysis process which yields metabolite concentration, % 
standard deviations and metabolite-to-creatine ratios.  An example of an output from 
LCModel showing input data, fit results and residual spectrum is shown in Figure 2.4.  
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Figure 2.4. Output from LCModel analysis showing bottom panel with in vivo data and 
baseline estimation in black, LCModel fit in red and top panel with the residual spectrum. 
 
The results from LCModel analysis have metabolite-to-creatine ratios and the 
measurement precision associated with each measurement.  The % SD in the output from 
LCModel analysis is not a traditional standard deviation of the measurement that is 
reported but the estimate of the lower bound on the measurement precision also called the 
Cramer-Rao Lower Bounds (CRLB). The results from LCModel analysis represent the 
nominal precision of the metabolite ratios (20, 21) such that the lower CRLBs denote 
metabolites quantified with higher precision and metabolites with CRLBs lower than 
10% from LCModel are widely accepted. 
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2.7 Cramer-Rao Lower Bounds 
 
CRLB represents the lowest variance of an estimate. CRLB can, therefore, give 
an estimate of the best measurement precision achievable for the given set of parameters 
like echo-time, pulse sequence, SNR, linewidths, etc. There have been studies aimed at 
assessing optimal measurement parameters by analyzing spectra acquired with different 
pulse sequence at specific echo-times, analyzing the spectra in LCModel and identifying 
the parameters with lowest CRLBs as the optimal method of measuring specific 
metabolites (22, 23) .  
The issue with identifying the optimal parameters from studying a subset of 
parameters is that the sampled subset might not consist of the optimal parameter.  A more 
reliable study would be to include a full set of parameters to identify the set with the 
lowest CRLB i.e. the highest possible precision.  While in vivo and in vitro studies with a 
complete sampling scheme are not feasible, calculations of theoretical CRLBs from 
composite spectra generated using simulated basis set are attainable.  Considering the 
spin systems of metabolites of interest are widely available, generation of basis sets for 
different pulse sequence and a range of echo-times and calculating the theoretical CRLBs 
would be highly efficient in studying and maximizing the information content at different 
acquisition parameters.   
A detailed method for calculating CRLBs and its implementation in calculating 
the optimal echo-time for detecting different metabolites using PRESS sequence at 7 
Tesla is presented in Chapter 3.  
 
 27 
CHAPTER III 
 
 
OPTIMIZATION OF DETECTION PARAMETERS FOR METABOLITES AT 7 
TESLA 
 
3.1 Introduction 
     The detection and accurate quantification of brain metabolites in vivo by high 
resolution MR spectroscopy (MRS) continues to improve in parallel with increases in 
field strength, Larmor frequencies, and spectral resolution. Whereas a handful of methyl 
groups from abundant molecules such as N-acetylaspartate, creatine, and choline are 
routinely detectable at lower fields, the emergence of 7 Tesla instruments has made the 
measurement of less concentrated, coupled spin-systems, notably GABA and glutamate, 
more feasible. However, the transition to higher field also introduces new technical 
challenges, primarily because of constraints on current RF hardware, pulse designs, 
specific absorption rate (SAR) and field (B1 and B0) uniformities. At 7 Tesla the 
radiofrequency wavelengths approach the dimensions of human brains and add to the 
difficulty in optimizing experimental protocols and RF waveforms and realizing the full 
benefit of moving to 7 Tesla.  
     During such a period of evolution, previously tested and familiar protocols, whose 
precision and robustness are well established at lower fields, must be updated. Increases 
in the available spectral resolution and sensitivity dictate that rigorous approaches for 
assessing the effects of sequence parameters be developed. For example, spectral editing 
is more important at lower fields as a strategy to counteract lower inherent resolution 
whereas the necessary RF bandwidths and relaxation rates increase at higher fields. 
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Methods that objectively quantify the precision of measurements can be used to provide 
useful guidance on the selection of methods and experimental parameters.  
     One approach is to estimate the theoretical precision of detecting and quantifying 
specific metabolite time-domain signals against a background of other known metabolite 
signals (24). Using Monte-Carlo methods, the precision is determined by the convergence 
of standard errors in linear regression fits in the presence of randomly varying noise. For 
an unbiased estimator, these errors converge to the Cramer-Rao lower bounds (CRLBs) 
at a fraction of the computational cost. CRLBs therefore offer a direct and rapid method 
of comparing the impact of experimental variables on the nominal precision of metabolite 
measurements (25, 26).  
     Measurement precision has been previously evaluated for subsets of available field 
strengths, commonly measured metabolites, and various pulse sequence parameters. 
However, comprehensive assessments of metabolite precision and their variations with 
echo-time and resolution at 7 Tesla have not been reported. Hancu et al. acquired in vivo 
data on a 3 Tesla system at five echo-times (15, 35, 45, 80 and 144 ms) and evaluated the 
relative precision based on CRLBs obtained from LCModel (19, 22). By comparing 
spectral overlap between 2.3 -2.45 ppm, Snyder et al. determined that the optimal echo-
time for Glu and Gln is 109 ms at 7 Tesla. Along with these studies, a basis for the 
theoretical bounds on precision for practical MR pulse sequences across a range of 
acquisition parameters would be valuable for developing high field detection strategies. 
     We have calculated CRLBs for 17 human brain metabolites that are at or near the 
detection threshold as a function of echo-time and resolution in PRESS. This analysis 
was extended to include projected 2-d acquisitions (TE-averaged) with all permutations 
 29 
of uniform echo-time spacing. We anticipate that these results will be useful as a guide 
for estimating nominal precision of metabolite measurements at 7 Tesla. 
 
3.2 Methods  
 
3.2.1 Spectral Simulation 
 
    Basis spectra were calculated using programs written in C++ with the GAMMA 
libraries (27), as previously described (11). Seventeen metabolites were chosen to 
represent the most concentrated brain metabolites, and although some are currently 
undetectable, these compounds contribute to the theoretical precision of their more 
abundant counterparts and are therefore included in the analysis. Spin-systems were taken 
from Govindaraju (15) and density matrices were propagated in 1 ms increments over 
echo-times ranging from 30 to 180 ms by varying the second refocusing period in PRESS 
(28). Simulated metabolite concentrations for 10 of the 17 metabolites are shown in Table 
3.1 (complete set with CRLBs in Appendix B.1). Spectra were normalized by 
incorporating within each spin-system a singlet reference peak well outside the 
bandwidth of interest (15 ppm).  
 
Met Cre GABA Gln Glu Gsh mI NAA NAAG PCh sI 
[C] 8.0 1.5 4.5 10.0 2.0 6.5 15.0 2.0 2.0 0.5 
 
Table 3.1. Metabolite concentrations used in simulations. 
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3.2.2 Statistics  
 
     CRLBs  (20, 29) were calculated with the expression given in Cavassila et al (24). 
Measured in vivo spectra   
€ 
Y vk( )   at frequency   were modeled as: 
   
€ 
Y vk( ) = X vk( ) + e vk( )   (3.1) 
and 
 
€ 
X vk( )= ClMl
l=1
N
∑ vk( )    (3.2) 
where 
€ 
Ml  are the simulated basis set spectra,  is the concentration of metabolite l, and 
  
€ 
e vk( )  represents Gaussian white noise with a standard deviation σ2.   
€ 
Y vk( ) , 
€ 
Ml vk( )  and 
  
€ 
e vk( )  are complex numbers with the assumption that the standard deviation of the real 
and the imaginary parts of the noise are equal. This model can be cast in matrix form as 
follows: 
       
€ 
Y = MTC + e      (3.3) 
     The general method to calculate CRLBs requires inverting the Fisher information 
matrix , where 
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 (3.4) 
 
 and  stands for the expectation. In the context of this study,  simplifies to  
 
  
€ 
F =
Re MHM( )
σ2
 (3.5) 
 
Here   
€ 
M  is a N x 17 matrix which contains 
€ 
Ml vk( )  as columns,   
€ 
MH  denotes the Hermitian 
conjugate of   
€ 
M , and  stands for the real part. Finally, the CRLBs are obtained as the 
square roots of the diagonal entries of the inverse of : 
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€ 
CRLBs = diag F−1( )⎛ ⎝ ⎜ 
⎞ 
⎠ 
⎟   (3.6) 
 
     CRLB calculations were first validated by comparison to Monte Carlo simulations, 
where experimental cut-off was chosen based on convergence of NAA standard 
deviations to 0.01% (number of repetitions, n = 4000). The magnitude of the Gaussian 
distributed noise was adjusted to match the signal-to-noise achieved in in vivo spectra 
with respect to NAA data averaged over 8 minutes from a 40 x 30 x 15 mm3 voxel at 7 
Tesla on a Philips Achieva human scanner (Philips Healthcare, Best, The Netherlands). 
Metabolite bases were broadened to match in vivo Cre linewidths (3.03 ppm resonance, 
linewidth = 10.3 hz). For extension to a range of transverse relaxation times, CRLBs 
were modeled for T2 = 109 ms and T2 = 158 ms. These values correspond to reported 
T2s for Cre (109 ms) and NAA (158 ms) at 7 Tesla (30).  The standard deviation of 
individual fits mirrored the calculated CRLBs, in accord with theory. Monte Carlo 
simulations were also used to interrogate cases where 2-hydroxyglutarate was: i) included 
in the composite spectra and in the basis set, ii) included in the composite spectra but not 
in the basis set, and iii) included in the basis but not in the composite spectra.  
 
3.2.3 In vivo experiments.  
 
     For comparison to simulated bases at calculated extrema, in vivo data were acquired at 
7 Tesla on a Philips Achieva human scanner from 40 x 30 x 15 mm3 voxels placed in the 
anterior cingulate cortex of two healthy volunteers, scanned in accordance with a 
protocol approved by the Vanderbilt University Institutional Review Board. 128 single 
echo transients localized with PRESS were acquired with TE/TR = 109/4000 ms. 
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Individual free-induction decays were frequency and phase corrected prior to averaging 
using a previously reported post-processing algorithm (4) 
    
3.3 Results and Discussion 
 
Figure 3.1. Dependence of metabolite lower bounds of precision (CRLBs) on echo-time 
for T2 = 109 ms. 
 
TE 
(ms) 
Cre GABA Gln Glu Gsh mI NAA NAAG PCh sI 
T2 = 109 ms 
30 1.2 11.1 7.6 2.5 3.5 1.2 0.3 2.2 3.1 4.8 
109 2.6 9.1 4.1 1.7 4.9 3.4 0.7 4.6 6.1 9.8 
T2 = 158 ms 
30 1.1 10.2 7.0 2.3 3.2 1.1 0.3 2.0 2.8 4.4 
110 1.9 6.6 3.0 1.2 3.6 2.6 0.5 3.4 4.5 7.3 
 
Table 3.2 CLRBs for PRESS acquisitions at 30 and 109 ms between T2 bounds of 109 
and 158 ms. 
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3.3.1 CRLB trends with echo-time  
 
     Figure 3.1 shows theoretical CRLBs as a function of echo-time for 10 of the 17 
metabolites used in this study.  The full set of CRLB curves is included in Appendix B2. 
There are three distinct trends in metabolite Cramer-Rao Lower Bounds (CRLBs) in 
PRESS sequence over the echo-time range from 30 to 180 ms (Figure 3.1). Nominal 
precision decreases with echo-time from 30 ms to a minimum (CRLB peak) for most 
metabolites at approximately 50 ms in the first major trend. This trend begins at 0 ms, but 
echo-times less than 30 ms were excluded from further analysis because they are not 
practical at 7 Tesla with this sequence. 
     Progressing to higher echo-times, in the second major trend methylene spin-systems 
(e.g. AA’XX’) begin to refocus. Relative to the global minimum for all metabolites at TE 
= 0 ms, a secondary trough develops at ~ 110 ms which is most pronounced for GABA, 
Lac, Glu and Gln (Figure 3.1). Two distinct peaks for Glu and Gln are visible at 109 ms 
and coupled with minima for CRLB allows simultaneous detection of Glu and Gln  
(Table 3.2, Figure 3.2). A spectrum obtained in vivo at an echo time of 109 ms is shown 
in Figure 3.2. This finding agrees with the optimal PRESS echo-time previously reported 
by Snyder et al (31). 
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Figure 3.2. In vivo spectrum shown with 3 spectral bases (glutamine, glutamate, inositol) 
at the echo time optimum for Gln and Glu (109 ms) at 7 Tesla.  
 
 
   Beyond this CRLB trough at 110 ms, precision uniformly decreases in the third trend as 
CRLBs are dominated by coupled spin modulation with an added effect from T2 
dephasing. We observe increasingly heavy penalties for attempting metabolite 
measurements with PRESS at echo-times greater than 110 ms. 
 
3.3.2 CRLB vary with molecular structure  
 
     The dominant trends shown in Figure 3.1 can be further subdivided by molecular 
structure. The set of detectable in vivo metabolites can be roughly divided into 4 groups: 
1) amino acids (Glu, Gln and GABA), 2) molecules with uncoupled methyl groups 
(NAA, Cre, Cho), 3) carbohydrates (mI and stereoisomer sI), and 4) peptides (NAAG and 
GSH). Molecules with coupled methyl protons such as Lac and Ala exhibit harsh 
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penalties progressing from TE = 0 to 50 ms and deep oscillations at echo times greater 
than 100 ms. 
     Uncoupled methyl protons contain intense absorptive resonances that do not modulate 
as a function of echo-time. The corresponding dependence of CRLBs on echo-time 
reflects this – the precision of NAA, Cre, and Cho decrease monotonically with T2 
relaxation. These molecules also feature the lowest CRLBs overall, and can be measured 
with high precision across the range of 30-110 ms considered here. Amino acids on the 
other hand, are also of broad interest and require more careful planning for optimal 
measurement efficiency. 
     Amino acids present in brain tissue and detectable by 1H MRS include the major 
inhibitory neurotransmitter (GABA), the major excitatory neurotransmitter and metabolic 
intermediate (Glu), as well as the most abundant amino acid in circulation (Gln). At 
typical in vivo concentrations (11), GABA is not detectable with a CRLB less than 10% 
with PRESS at 7 Tesla at any echo-time with the SNR considered in these calculations. 
Even at 7 Tesla, spectral editing or 2-dimensional methods are therefore required to 
measure GABA. Glu and Gln are more concentrated, and Glu in particular is sufficiently 
abundant to be detected either at short echo-times near 30 ms or at the global minimum 
(109 ms, for echo-times > 30 ms). At approximately half the concentration of Glu, Gln 
will likely be difficult to detect at echo-times other than the optimal (110 ms at T2 = 109 
ms). This agrees with a recent study by Snyder et al, which showed that minimum 
overlap for Glu and Gln was near 110 ms and independent of the way the individual 
echoes were distributed (31).  
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    These results are also consistent with analyses that focused only on the 2.2 – 2.6 
ppm range for Glu and Gln and that support an echo time of 110 ms (32, 33). Our results 
are in excellent agreement with these studies despite the use of different analysis 
methods. Downfield resonances at 3.75 ppm are of limited value for Glu and Gln 
quantification because their chemical shifts and J-couplings are nearly identical; they act 
only to constrain the model in the more upfield region that is characterized by mutually 
exclusive information content.  
     The third major set of components of human brain spectra considered here are 
inositol compounds. These are synthesized from glucose and of the 8 isomers, mI and to 
a lesser extent sI are present in sufficient abundance to be detected in human brain. 
Methyl groups and amino acids demonstrate monotonic increases and global minima near 
110 ms, respectively, and, in contrast, the CRLBs in mI and sI display shallow minima at 
70 ms before losing precision at higher echo-times (Figure 3.1). Given this behavior, the 
amino acids and inositol compounds cannot be simultaneously measured with optimal 
precision at a fixed echo-time. 
     The final classes of compounds considered here are peptides. NAAG and Gsh are di 
and tripeptides, respectively, and feature CRLB trends that are distinct from the other 
compounds presented above. In both cases, the trends most resemble the monotonic 
increases seen in methyl-bearing molecules, suggesting that the added J-coupled 
resonances add negligible spectral information. In contrast to Glu and Gln for example, 
the CRLBs of GSH and NAAG exhibit very shallow minima in measurement precision 
beyond 50 ms.  
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3.3.3 CRLB dependence on linewidth.  
 
  
Figure 3.3 Dependence of metabolite lower bounds of precision (CRLB) on resolution for 
T2 = 109 ms 4 to 24 Hz. 
 
 Cre GABA Gln Glu Gsh mI Lac NAA NAAG PCh sI 
a 0.41 0.66 0.24 0.10 0.33 0.33 0.55 0.05 0.36 0.72 0.85 
b 1.50 2.32 1.71 0.67 1.41 0.15 4.49 0.11 0.91  -1.27 1.28 
r2 0.98 1.00 1.00 1.00 1.00 0.99 1.00 1.00 1.00 1.00 0.99 
 
Table 3.3. Linear (y = ax + b) fit of CRLB (y) versus linewidth (x) centered at TE = 109 
ms. 
 
    The dependences of CRLBs on linewidth are shown in Figure 3.3. These are estimated 
for TE = 109 ms and displayed in Hz. Linear slopes (CRLB/Hz, Table 3.3) range from 
0.05 (NAA) to 0.85 (sI) with minimum and maximum intercepts at 4 Hz ranging from 
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0.37 for NAA to 6.63 for Lac. The intercepts depend on concentration (Table 3.1). For 
the concentrations used in this study, the CRLB for Glu is relatively insensitive to 
linewidth near the optimal echo-time. However, as echo-times move away from this 
trough, resolution must increase to maintain a constant CRLB. This can be seen from the 
isolines plotted against linewidth (FWHM) and echo-time in Figure 3.4.  
 
3.3.4 Strategies for simultaneous detection of inositol compounds and amino acids.  
 
     The CRLB contours for Gln are similar to Glu in Figure 3.4 and, in both cases, 
measurement precision becomes increasingly less sensitive to linewidth when echo-times 
move from 45 toward 110 ms (Figure 3.4). Contrasting with the CRLB surfaces of these 
2 amino acids, mI and sI require increasing resolution to maintain constant precision with 
echo-times greater than 95 ms. These CRLB contour plots preclude simultaneous 
detection of Glu, Gln and mI and sI at one echo time.  
 
 
 
Figure 3.4.  CRLBs of glutamate (left), glutamine (center), and inositol (right) as a 
function of resolution (FWHM) and echo time at a proton frequency of 300 MHz (7 
Tesla). Isolines for 5 and 10% CRLB are shown in blue and purple. 
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   At the transverse relaxation rates used in these calculations (109 ms and 158 ms) (30), 
Glu and Gln are detected with maximum precision at ~110 ms (109 ms for Glu), while 
measurement of mI is most favorable at 30 ms and the secondary CRLB trough at 78 ms. 
The CRLB for Glu and Gln increases from 1.7 and 4.1 at 109 ms to 2.4 and 6.2 at 78 ms, 
respectively. The CRLB for mI increases from 1.8 at 78 ms to 3.4 at 109 ms. The optimal 
measurement strategies for this metabolite subset depend on how much precision can be 
sacrificed for either compound of interest (Glu/Gln versus mI). Single echoes may be 
chosen for individual measurements, but the most efficient use of spectrometer time 
would divide attention between the respective metabolite optima in paired echo averages.    
      Sequences which average echo acquisitions with linearly increasing echo-times are 
referred to as TE-averaging (34). While research groups have found value in averaging 
echo-times in the range of 35-185 ms at 3 Tesla, these sequences are found to be less 
appropriate for a range of metabolites including Glu and Gln at 7 Tesla when considering 
CRLBs in the model used here. Adding echoes reduces precision for a given metabolite 
relative to its CRLB minimum, but the practice is useful for making efficient use of 
spectrometer time when the objective is to make measurements with optimal precision in 
sets of metabolites. Under these conditions, combining echo-times in a single scan 
eliminates the necessity of starting and restarting the acquisition, while reducing the 
number of data sets for post-processing and analysis by 50 percent.   
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3.3.5 CRLBs with TE-averaging schemes 
 
     Figure 3.1 illustrates how precision of measurement varies for each of 10 metabolites 
against a background of Gaussian distributed noise. For any single metabolite, averaging 
echoes away from the optimum value reduces precision. The rate that penalties in 
precision accrue depends on the sharpness of the CRLB minima for each metabolite. For 
any pair of metabolites of interest, averaging echoes will be less precise for each 
compound. 
 
Figure 3.5. Metabolite CRLBs in projected 2-d sequences. These curves represent the 
CRLB of echo-time averages where the starting echo series ranges from 45 to 100 ms in 
1 ms increments. For example, the first point includes the CRLB from echoes over the 
range from 45-100 ms, whereas the last point spans 100-120 ms. 
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Cre GABA Gln Glu Gsh mI NAA NAAG PCh sI 
Signal average of 30 and 109 ms 
 1.7 11.3 6.1 2.1 4.4 2.0 0.4 3.0 4.7 6.2 
Signal average of 35 and 118 
 1.8 11.6 7.0 2.8 4.8 2.6 0.5 3.2 5.1 6.6 
Signal average of 78 and 109 
 2.2 11.7 5.4 2.1 4.8 2.4 0.6 4.1 5.7 8.1 
35 to 185 ms in 10 ms increments 
 2.4 17.8 10.9 3.7 6.0 4.1 0.6 4.5 6.9 8.8 
 
Table 3.4. CRLBs for echo averaging schemes with T2 at 109 ms.  
 
   A snapshot of the performance of averaging schemes is illustrated in Figure 3.5. The 
ordinate in this figure represents the starting average in uniformly sampled data ranging 
from 45 to 100 ms. Hence, increasing initial echo-time corresponds to fewer echoes 
averaged along with a concomitant bias to higher echo-times. The amino acids and Lac 
benefit from this bias and CRLBs can be seen to converge to their respective single echo 
minima, while other metabolites (with more favorable CRLBs at lower echo-times) 
become increasingly worse. 
    The trade-offs involved in projecting (averaging) echoes can be seen from Figure 3.1 
and the prior discussion of CRLB trends as a function of echo-time and molecular 
structure. Amino acids such as Glu and Gln feature large CRLB oscillations with primary 
troughs at ~109 and 30 ms. Stereoisomers of inositol, such as mI and sI, have primary 
and secondary troughs at 30 and 78 ms, respectively. The measurement precision of both 
amino acids and inositols are heavily penalized at CRLBs near 50 ms. Methyl-bearing 
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molecules are driven by T2 losses and CRLBs increase monotonically across the range of 
analysis considered here (30-300 ms). While single echoes at respective optimum echo-
times outperform projected sequences uniformly, when inositols and amino acids are of 
interest, combining 30 and 109 ms or 78 and 109 ms would be expected to provide the 
best compromise and reduce scan-time. According to our simulations, 30 and 109 ms 
should outperform other averaging schemes and lead to the most efficient use of scan 
time for detection of all three major subdivisions considered here (Table 3.4). To the 
extent that other metabolites are of interest and not included (such as Lac), modifications 
will be necessary but optimal conditions are straightforward extensions of the analysis 
presented here.  
 
3.3.6 Basis set composition 
 
Figure 3.6. The dependence of concentration on basis set composition. When 2-
hydroxyglutarate is physically present but not used in the fitting for quantification, the 
concentration of glutamate, glutamine, and γ-aminobutyric acid are overestimated (gray 
trace) relative to input concentrations (black trace). 
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     Figure 3.6 shows the results from quantification of metabolites, concentration and 
associated CRLBs from a system of 18 metabolites that include 2-hg in addition to the 17 
metabolites discussed above.  The two cases shown are: i) inclusion of 18 metabolites in 
both the composite spectrum and the basis set, and ii) exclusion 2-hg in the basis set but 
inclusion in the composite spectrum generated from 18 metabolites. Monte-Carlo 
simulation results show agreement between CRLBs from cases i) and iii) , whereas case 
ii) shows overestimation of concentrations of Glu, Gln, GABA and Asp. For example, 
addition of 4 mM of 2-HG in the composite spectra and absence in the spectral basis set 
resulted in the output concentration of glutamate, glutamine and GABA to be estimated 
as 10.8, 4.8 and 2.8 mM when there was only 10, 4.5 and 1.5 mM of these metabolites in 
the composite set respectively as can be see from Figure 3.6. However, this 
overestimation of concentration is not reflected in the metabolite precision from these 
experiments. This suggests that excluding metabolites in the basis set that are present in 
the experimental data leads to an error in concentration estimates without the information 
being reflected in error estimates.  
 
3.4 Conclusions 
 
     Metabolite precision as a function of echo-time was studied at 7 Tesla at resolutions 
typical for human brain. Theoretical Cramer-Rao lower bounds (CRLBs) were used to 
determine nominal measurement precision for 17 metabolites in order to tailor optimal 
detection strategies for PRESS and TE-averaged acquisitions. Standard deviations from 
Monte Carlo simulations converged to CRLBs for subsets of the echo-times analyzed, 
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validating the previously reported algorithm (24). Whereas the relationship between 
CRLBs or Monte Carlo and in vivo data depend on prior knowledge of the model, and in 
particular the baseline and noise, the trends with echo-time are likely dominated by 
chemical shift and J-modulation. 
     The theoretical CRLBs of human brain metabolite spectra as a function of echo-time 
in PRESS suggest that trends in precision are dominated by structural motif. This occurs 
despite a range of J-couplings because CRLBs are driven by evolution against the 
evolution of background metabolites. For example, the chemical shifts and J-couplings in 
glutamine and glutamate are similar, yet display a detection optimum within a 
millisecond (109 versus 110 ms). Using these overall trends, the detectable metabolites 
can be approximately subdivided into 4 classes (excluding lactate).   
     Optimal precision of amino acids and carbohydrates is mutually exclusive in the range 
of echo-times studied here (30 ms to 180 ms). When molecules from these classes are 
targeted, the required precision should be balanced with approximate concentrations and 
echo-times weighted accordingly. TE-averaged data can be acquired with standard 
scanners, and the use of multiple echoes in PRESS has been previously explored for 
measuring glutamate (34). While additional factors could make these strategies 
advantageous, analysis of the CRLBs suggests that the number of sampled echoes should 
equal the number of mutually exclusive molecular classes being examined. For example, 
when carbohydrates and amino acids are of interest, an efficient sampling scheme simply 
toggles between the respective optima. This solution consolidates both acquisition and 
analysis while maintaining optimal overall precision on a pair of metabolites where 
CRLB minima do not overlap. 
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     We found that missing metabolites in the basis set that are present in the experimental 
data leads to overestimation of other metabolites, having a complete basis set that 
includes metabolites, like 2-hg, that might only be present in patients with IDH-2 
mutations, does not reduce the accuracy of the metabolite quantification. 
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CHAPTER IV 
 
 
IMPLEMENTATION AND COMPARISON OF GABA MEASUREMENTS AT 3 
TESLA AND 7 TESLA 
 
4.1 Introduction 
 
     GABA is a major inhibitory neurotransmitter and abnormal levels of GABA are 
associated with various neuropsychiatric disorders. For example, lower levels of GABA 
have been observed in patients suffering from depression and schizophrenia (35, 36). 
However, measurements of GABA are difficult because the concentration is low (around 
1 mM), which is at the detection threshold of MRS measurements in reasonable times. 
Moreover, there is significant spectral overlap from resonances from methyl groups like 
NAA and Creatine that have concentrations that are at least four times that of GABA, so 
spectral editing techniques are essential to select and quantify GABA in vivo.  Various 
methods have been proposed and used, and among these different spectral editing 
techniques, one of the widely used sequence is J-difference editing, which is performed 
by employing the MEGA-PRESS sequence (3).  The pulse sequence diagram for the 
MEGA-PRESS pulse sequence is shown in figure 4.1.  
 
(Waddell et al 2007)  
Figure 4.1. MEGA-PRESS J-difference editing pulse sequences. 
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     With the advent of increased field strength and accompanying SNR, the development 
of specialized pulse sequences and advances in data correction and analysis techniques, 
there is increased interest in measuring GABA despite the previous difficulties to detect it 
reliably (37, 38).    In particular, the emergence and wider use of 7 Tesla MR scanners 
brings with it the potential for acquiring data with higher signal-to-noise ratio and better 
spectral resolution. Moving to a different static magnetic field strength affects some of 
the metabolites MR properties such as T1 and T2 relaxation times as well as chemical 
shift dispersion, which imposes the demand for proportionately larger RF excitation 
bandwidths. Longer T1 relaxation times requires longer repetition times to allow 
recovery of the magnetization, which lengthens the duration of the scan while shorter T2 
relaxation times result in faster signal decay and broader lines and signal bandwidths as 
we go to higher field strength.  
     One of the factors that potentially affects the measured concentration of GABA is 
contamination from macromolecular resonances that are known to co-edit with GABA 
with most GABA editing sequences (39-41).  Macromolecules usually have shorter T2 
relaxation times and hence we would expect to have decreased contamination from 
macromolecules at 7 Tesla compared to 3 Tesla.  However, the assessment of the 
differences in the degree of contamination from macromolecule is beyond the scope of 
this study and is not considered here. 
     Here, we compare the performances and results of measuring GABA in human brain 
using both 3T and 7T systems. We report on measured differences between the 
neurotransmitter concentrations observed between 3 Tesla and 7 Tesla and assess the 
bandwidth requirements for making metabolite measurements with higher precision at 7 
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Tesla.  We believe these results will be helpful in identifying the parameters necessary 
for increasing the quantification accuracy of GABA and improve the measurements at 7 
Tesla. 
 
4.2 Methods 
 
     15 volunteers were scanned for this study using protocols approved by the Vanderbilt 
University Institutional Review Board.  All scans were performed on 3 Tesla and 7 Tesla 
Philips Achieva MR Scanners (Philips Healthcare, Best, The Netherlands). A birdcage 
transmit/receive head coil was used for 3 Tesla experiments and a volume transmit head 
coil (Nova Medical, Inc, Burlington, MA, USA) in combination with a 16-channel 
receive coil (Nova Medical, Inc, Burlington, MA, USA) was used for 7 Tesla 
experiments. 
 
4.2.1 Imaging 
 
     Anatomical images were acquired using T1-weighted turbo field echo (TFE) sequence 
with 1x1x2 mm3 resolution, TE/TR = 3.19/6.54 ms, field-of-view (FOV) size of 
240x240x170 mm3, number of slices = 85 with 64x63 pixels, water-fat shift = 2.02 pixels 
for a scan time of 5 minutes. All anatomical images were acquired in sagittal planes and 
reformatted to generate axial and coronal planes for accurate voxel placements.  
 
4.2.2 Spectroscopy 
 
     All spectroscopy data were acquired from a 40x30x15 mm3 voxel in the anterior 
cingulate cortex (ACC).  The data were first acquired at 7 Tesla and the voxel at 3 Tesla 
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was specified to match the voxel used for 7 Tesla measurements using screen grabs of 
voxel location in all three planes from 7 Tesla as reference for each subject. 
 
3 Tesla vs 7 Tesla measurements 
 
     11 subjects were first scanned at 7 Tesla and then at 3 Tesla with the voxel location 
matched to the one used at 7 Tesla. At 3 Tesla, 512 transients were acquired with a 
transmit/receive birdcage coil with a maximum B1 of 23.5 µT. The data were acquired 
using MEGA-PRESS sequence with TE/TR = 73/2000 ms with 2048 points in the FID, 2 
kHz receiver bandwidth.  The frequency selective pulses had a bandwidth of 64 Hz for 
GABA editing and were alternated between 1.9 ppm on odd acquisitions and at 7.4 ppm 
on even acquisitions. Four outer volume suppression bands and a sinc-gauss pulse with 
130 Hz bandwidth for water suppression were applied before the MEGA-PRESS pulse 
sequence and the slice-selective pulses were centered on 2.02 ppm. 
     At 7 Tesla, 256 transients were acquired with a volume transmit/receive coil with a 
maximum B1 of 15 µT  and the 16 channel SENSE coil as the receive coil. The data were 
acquired using a MEGA-PRESS sequence with TE/TR = 73/4000 ms with 2048 points in 
the FID, 3.5 kHz received bandwidth.  The frequency selective pulses had a bandwidth of 
149 Hz for GABA editing and were alternated between 1.9 ppm on odd acquisitions and 
at 7.4 ppm on even acquisitions.  MOIST water suppression with a bandwidth of 150 Hz 
along with four outer volume suppression bands was applied prior to the localization 
pulse sequence and the slice-selective pulses were centered on 2.02 ppm. 
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Bandwidth effect at 7 Tesla 
 
     Three sets of GABA edited spectra were acquired from the same voxel location with 
the RF pulse centered on NAA at 2.02 ppm from 4 volunteers. The manufacturer set 
maximum B1 was overridden from 15 µT to 18 µT. Three sets of data were acquired by 
applying RF pulses with maximum B1 of 15 µT, 16.5 µT and 18 µT to study the effect of 
pulse bandwidth at 7 Tesla. The slice-selective excitation and refocusing pulses used in 
this study and their corresponding pulse profiles are given in Figure 4.1.  The bandwidths 
of the excitation pulses and the refocusing pulses at different RF amplitude are given in 
Table 4.1.  
  
Figure 4.2. Pulse profile (top) and frequency response (bottom) for a) excitation  pulse 
and b) refocusing pulse used in the study. 
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  Excitation pulse Refocusing pulse 
  spredrex gtst1203 
B1 (uT) Time (ms) BW (Hz) Time (ms) BW (Hz) 
15 6.41 2210 6.22 1405 
16.5 5.83 2431 5.65 1546 
18 5.34 2652 5.18 1686 
23.5 4.09 3463 3.97 2202 
 
Table 4.1. RF amplitude (B1), corresponding pulse duration and pulse bandwidth (BW) 
of the excitation (spredrex) and refocusing (gtst1203) pulses used in the study. 
 
4.2.3 Post-processing 
 
     All datasets were zero filled to 8192 points and line broadened with a 2 Hz frequency   
and phase-corrected using programs written in Matlab using the 3.03 ppm singlet peak 
from Creatine as reference. After the frequency and phase corrections, the even 
acquisitions were averaged into an even spectrum and the odd acquisitions into an odd 
spectrum. The even spectrum was subtracted from the odd spectrum to generate the J-
difference spectrum. 
 
4.2.4 Analysis 
 
     Full density matrix simulations were performed for PRESS and MEGA-PRESS 
sequences using ideal pulses as slice-selective pulses and real pulses as frequency-
selective editing pulses (in MEGA-PRESS) using programs written in C++ by 
incorporating GAMMA subroutines (17). The density matrices for the MEGA-PRESS 
sequence were sampled from 104 spatially resolved points within the voxel to account for 
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the differential impact of crusher gradients in the presence of spectrally selective editing 
pulses. The spin system were taken from the literature, the resulting spectra were 
normalized and formatted for use as a basis set in LCModel (Chapter 2). Metabolite 
concentrations from even and J-difference spectra from all volunteers were quantified 
using LCModel (19). 
 
4.2.5 Chemical shift displacement calculations 
 
     Slice-selective pulses have limited bandwidth and are applied in the presence of a 
magnetic field gradient in order to affect a specific target region of the sample resulting 
in a shift in the effective location of the selected slice for different resonances.  This shift 
is given by:  
 
  
€ 
Δx =
Δω
BWrf
x  (4.1) 
where  is the size of the voxel, 
€ 
Δω  is the difference in chemical shift between two 
protons,   
€ 
BWrf  is the bandwidth of the RF pulse,   
€ 
Δx  is the chemical shift displacement in 
the voxel direction (2).  Equation 4.1 was used to calculate the chemical shift 
displacement errors at 3 Tesla and 7 Tesla measurements and assess the bandwidth 
requirements of the RF pulses for the 7 Tesla measurements to be comparable to 3 Tesla 
measurements and also requirements to outperform 3 Tesla measurements. 
     Chemical shift displacement errors result in the spin system experiencing 4 different 
pulse sequences based on the location of the spins, with the spins experiencing: a) all 3 
pulses of the PRESS sequence, b) the 90o and first 180 o pulses, c) the 90o and the second 
180 o pulses, and d) only the 90 o pulse.  The GABA spectra generated from the different 
cases have been previously reported by Edden et al (42).  The signal detected from the 
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study is the sum of signals arising from all 4 regions and the result may therefore suffer 
from signal distortion. 
 
4.3 Results and discussion 
 
4.3.1 3T vs. 7T measurement 
 
 
Figure 4.3.  Even (top) and J-difference (bottom) spectra acquired at 3 Tesla (left) and 7 
Tesla (right) using MEGA-PRESS sequence at TE = 73 ms with editing pulse bandwidth 
of 0.5 ppm toggled between 7.4 and 1.9 ppm on even and odd spectra respectively 
acquired from a 40x30X15 mm3 voxel from anterior cingulated cortex. 
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Figure 4.4.  Comparison of metabolite-to-tCr ratios averaged from even analysis of 11 
data sets acquired at 3 Tesla and 7 Tesla.   
   
Figure 4.4 shows large discrepancies in [met]/[tCr] ratios between the even data acquired 
at 3 Tesla with B1 = 23.5 µT and 7 Tesla with B1 = 15 µT. The ratio of [NAA/tCr] was 
measured to be 1.65 at 7 Tesla vs 1.24 at 3 Tesla, [Glx/tCr] was 0.73 at 7 Tesla vs 0.96 at 
3 Tesla and [Ins/tCr] was 0.22 at 7 Tesla vs 0.80 at 3 Tesla.  The higher ratio of 
[NAA/tCr] at 7 Tesla denotes smaller peaks from Creatine measured at 7 Tesla than at 3 
Tesla.  As we move to metabolites that have resonances downfield from the center 
frequency of NAA (2.02 ppm) of the slice-selective pulses, the measured metabolite 
ratios get smaller at 7 Tesla in comparison to 3 Tesla. 
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 Figure 4.5. Comparison of metabolite-to-NAA ratios averaged from j-difference analysis 
of 11 data sets at 3 Tesla and 7 Tesla.   
 
     The results in Figure 4.5 from analysis of J-difference spectra show that 
[GABA/tNAA] measured at 7 Tesla was only 0.28 times the ratio measured at 3 Tesla 
and [Glx/tNAA] at 7 Tesla was 0.33 times that at 3 Tesla.  The large discrepancy cannot 
be accounted for with the consideration of T2 relaxation rate differences and the 
decreased macromolecule contamination at 3 ppm for GABA measurement at 7 Tesla.  
The results make it apparent that the effects of chemical shift displacement errors with 
the maximum B1 of 15 µT used for 7 Tesla measurements are a setback to realizing the 
full benefit of moving to 7 Tesla from 3 Tesla and needs to be further analyzed. 
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4.3.2 Effect of RF and bandwidth at 7 Tesla 
 
  
Figure 4.6. Comparison of metabolite-to-tCr ratios averaged from even analysis of 4 data 
sets acquired with RF amplitudes of 15, 16.5 and 18 µT.   
 
     Averages from analyses of 4 even data sets acquired from using three different B1 
values, 15, 16.5 and 18 µT are shown in Figure 4.6.  [tNAA/tCr] ratio decreases from 
1.70 to 1.55 and 1.52 as the RF amplitude of the slice-selective pulses increase from 15 
µT to 16.5 µT and 18 µT respectively.  As the RF amplitude of slice-selective pulses 
increased from 15 µT to 16.5 µT to 18 µT, increases in ratios of [Glx/tCr] and [Ins/tCr] 
were also observed as is shown in Figure 4.6.  Significant changes in [tCh/tCr] were not 
observed possibly due to the proximity of tCh and tCr resonances which are located at 3.2 
ppm and 3.03 ppm respectively with a difference of 0.2 ppm. 
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Figure 4.7. Comparison of metabolite-to-NAA ratios averaged from even analysis of 4 
data sets acquired with RF amplitudes of 15, 16.5 and 18 µT.   
 
     Figure 4.7 shows averages of [met/tNAA] from J-difference analysis of data sets 
acquired with B1 values ranging from 15 µT to 18 µT.  The figure shows increases in 
[GABA/tNAA] from 0.065 to 0.074 to 0.089 and [Glx/tNAA] from 0.407 to 0.430 to 
0.478 with increases in B1 from 15 µT to 16.5 µT to 18 µT. Even though increasing the 
RF amplitude by 1.5 µT for the slice-selective refocusing pulses used in this study 
increased the bandwidth of the pulses by a mere 10%, the improvement in quantification 
accuracy is evident. All these results confirm the notion that a large proportion of the 
discrepancy in the results between measurement at 3 Tesla and 7 Tesla was due to the 
increase in chemical shift displacement errors at 7 Tesla because of decreased bandwidth 
of the pulses. 
 
 4.3.3 Chemical shift displacement errors 
 
     The extent of chemical shift displacement errors between 1.91 and 3.01 ppm 
resonances of GABA and between 2.1 and 3.7 ppm resonances of Glutamate for the RF 
amplitude and pulses used in this study are shown in Table 4.2.  Table 4.2 shows a 
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chemical shift displacement error of 6.51 % and 9.53% between the resonances of GABA 
and of Glutamate respectively and displacements of 19% or more at 7 Tesla with the 
pulses used in this study with RF amplitudes of up to 18 µT. As the difference in 
chemical shift between two molecules or resonances increase, the chemical shift 
displacement errors also increase which results in incoherent averaging of the spectra 
generated from different compartments.  
B0 field (T) B1 (µT) BW (Hz) 
GABA (1.9-3.0ppm)  
% CS displacement 
Glu (2.1-3.7 ppm) % 
CS displacement 
7 15.0 1405 23.75 34.78 
7 16.5 1546 21.59 31.61 
7 18.0 1686 19.80 28.99 
3 23.5 2202 6.51 9.53 
 
Table 4.2. RF amplitudes, RF bandwidths and corresponding percent if chemical shift 
displacement errors in the voxel direction for a refocusing slice-selective pulse. 
 
     The consequence of having increased chemical shift displacement errors is more 
severe in a non-homogeneous sample like brain as opposed to a homogeneous sample 
like phantoms.  Even in the case of NAA and Creatine where the majority of signal 
contribution comes from the singlet peak, a big difference in [NAA/tCr] ratio was 
observed in this study.  Incoherent averaging is not the only contributor of this difference; 
the shifted volume could have a different composition of grey matter, white matter and 
cerebrospinal fluid (CSF) and different metabolite concentrations.  
      Calculation of bandwidth requirements at 7 Tesla shows that a refocusing pulse 
bandwidth of 5126 Hz at 7 Tesla would result in chemical shift displacements that equal 
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those from 3 Tesla for the pulses and B1 used in this study.  The measured [met/tCr] ratio 
would likely be smaller at 7 Tesla compared to 3 Tesla despite having a comparable pulse 
bandwidth due to the differences in T1 and T2 relaxation rates at the two field strengths 
and increased B1 and B0 inhomogeneities at 7 Tesla.  However, the decreased 
macromolecule contamination, increased SNR and increased spectral resolution offered 
at 7 Tesla could potentially help in quantification of metabolites with higher precision, 
provided we can implement pulses with higher bandwidth that are insensitive to B1 
homogeneities. 
 
4.4 Conclusions 
 
Our results show significant discrepancies in the metabolite-to-creatine ratios measured at 
3 Tesla and 7 Tesla with the pulses and bandwidths used in this study. Increasing the 
bandwidth of the pulses reduces the chemical shift displacement errors and differences 
between the measurements made at 3 Tesla and 7 Tesla.  Our study shows strong 
evidence of the requirement of having the bandwidth of the pulses comparable to that 
used on 3 Tesla for making better measurements at 7 Tesla. For the parameters used in 
this study, having slice-selective refocusing pulse bandwidths equal to or greater than 
5126 Hz at 7 Tesla would potentially yield measurements with higher precision and help 
realize the benefit of going to 7 Tesla. 
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CHAPTER V 
 
 
TIME-RESOLVED MRS 
 
5.1 Introduction 
 
     The human brain constitutes of 2% of the body’s mass but consumes almost 20% of 
the body’s energy metabolism at rest (43).  Functional Magnetic Resonance Imaging 
(fMRI) studies have helped identify those areas of the brain that increase neural activity 
during specific stimulations through the detection of corresponding hemodynamic 
changes (44).  The study of hemodynamic changes, while of great importance, provides 
only an indirect measure of neuronal activity.  Functional Magnetic Resonance 
Spectroscopy (fMRS) measurements have the potential of providing insights into the 
coupling between neuronal activity and metabolism and to the underlying biochemical 
changes that follow from changes in neural activation. There have been a number of 
previous studies performed to study the changes in metabolite profile during regional 
activation (14, 45-51) but these have had limited sensitivity and have used prolonged 
periods of activation, and thus cannot reveal any transient changes that might occur 
immediately after a stimulating event.  
     Measurement of concentrations for some metabolites is difficult due to their low 
concentration, for example, lactate and glucose. The overlap in signals from different 
metabolites also poses difficulty for accurate measurement of concentrations.  Hence, 
optimizing the measurement parameters and sensitivity is crucial for measuring 
metabolite concentrations as well as the changes in metabolite concentrations, which are 
likely to be even smaller.   
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      Due to the inherently low sensitivity of MRS measurements, averaging a number of 
transients is essential in order to achieve spectra with high enough signal-to-noise ratios 
(SNR) to accurately quantify metabolite concentrations. Thus a series of spectra cannot in 
general be acquired with high temporal resolution. Most previous studies have used block 
paradigms to study neuroenergetics.  Averaging spectra acquired over an extended period 
is appropriate for measuring metabolite changes that are sustained for longer durations 
but will miss any transient changes that happen within the activation block. The highest 
temporal resolution reported for a functional magnetic resonance spectroscopy study to-
date is 20 s (48). This leaves unanswered questions as to what may be happening in terms 
of neuroenergetics immediately after the onset of stimulus. For example, although some 
metabolites may change on average slowly as a result of continuing stimulations, over 
shorter times there may be larger increases and subsequent decays or wash-out that are 
undetected. Thus there is a need for a method that increases temporal resolution of 
functional MRS studies. Similar considerations have arisen in the field of functional MRI 
wherein the use of event-related designs allow temporal resolution of transient events that 
can be repeated. 
     The aim of this study was to implement a unique event-related binning method to 
measure transient changes in metabolite concentrations during regional activation with 
increased temporal resolution.  The binning method used in the study increases the 
effective temporal resolution significantly such that the temporal resolution is limited by 
the repetition time of the pulse sequence, and the SNR by the number of events that can 
be repeated in practice. 
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5.2 Method 
 
     Twelve volunteers were scanned in accordance with the protocol approved by the 
Vanderbilt University Institutional Review Board on a  3 Tesla Philips Achieva MR 
Scanner. A birdcage transmit/receive coil with a 30.0 cm diameter was used with a 
maximum B1 of 23.5 µT. 
 
5.2.1 Imaging 
 
     Anatomical images were acquired using T1-weighted turbo field echo (TFE) sequence 
with 1x1x2 mm3 resolution, TE/TR = 3.19/6.54 ms, field-of-view (FOV) size = 
240x240x170 mm3, number of slices = 85 with 64x63 pixels, water-fat shift = 2.02 pixels 
for a scan time of 5 minutes. All anatomical images were acquired in saggital planes and 
reformatted to generate axial and coronal planes for better voxel placement.  
     Functional MRI data sets were acquired using a T2*-weighted gradient-echo echo 
planar imaging sequence (GE-EPI) with the following parameters: FOV = 220 mm, 
TE/TR = 35/2000 ms, number of slices = 30, slice thickness = 3 mm, slice gap = 0.5 mm, 
30 slices. All functional images were axially oriented.  A full field-of-view black and 
white radial checkerboard flashing at 8 Hz frequency was used as stimulus for all the 
functional scans. The fMRI runs consisted of six blocks of 40 seconds each, where each 
block had 20 seconds of stimulus followed by 20 seconds of rest culminating in a total of 
240 seconds of scan time and 120 dynamics. IViewBold tool in the Philips MR scanner 
was used to generate activation maps in real-time during functional MRI sequences and 
the activation maps generated using IViewBold was used as a guide to place the voxels 
for acquiring spectral data. 
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5.2.2 Spectroscopy 
 
Water unsuppressed spectra 
 
     70 transients of water unsuppressed spectra were acquired in a series that consisted of 
3 cycles of 20 s rest followed by 20 s of stimulus at TE/TR = 60/3000 ms from the 
activation region to confirm the accuracy of the voxel placement using a PRESS 
sequence. Water peak height and corresponding water linewidth were calculated using 
custom-built programs written in MATLAB to ensure the voxel was placed in an 
activated region that demonstrated a BOLD response in the water spectra. The water scan 
was repeated at the end of the study as a quality control measure.  Any data set that 
lacked a BOLD response at the end of the scan reflected subject motion during the scan 
and the data were excluded from further analyses. 
 
Metabolite spectra 
 
     Subjects were scanned using two paradigms: the first constituted a block paradigm 
and the second consisted of an event-related paradigm.  
 
Block paradigm 
 
     Metabolite spectra were acquired from the activated region using a MEGA-PRESS 
sequence for lactate editing (3).  An editing pulse with 64 Hz bandwidth was applied and 
the editing frequency was toggled between +/- 60 Hz to produce a refocused lactate peak 
at 1.3 ppm on odd scans.  Editing frequency was set to -60 Hz during odd scans and to 
+60 hz during even scans.  Water suppressed functional MR spectra were acquired with 
an initial 4 minute resting state block followed by two cycles of 8 minutes of activation 
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blocks and 8 minutes resting state blocks.  Each transient was saved separately and were 
corrected for frequency and phase variations with the Creatine peak as the reference peak 
using custom-built programs written in MATLAB (4). The data were binned into 2 sets: 8 
minute blocks and one-minute blocks, after which odd and even spectra were generated 
for each of the blocks.  
 
Event-related paradigm 
 
     The paradigm consisted of 32 cycles of 32 seconds of activation followed by 32 
seconds of rest. A MEGA-PRESS sequence with editing pulse at 4.1 ppm resonance 
frequency to refocus the lactate peak at 1.3 ppm and TE/TR = 73/2000 ms was used to 
acquire water suppressed spectra from the activated region. Each transient was saved 
separately and was frequency and phase corrected using custom-built programs written in 
MATLAB. The data were binned based on the time of acquisition after the onset of 
stimulation in order to achieve an effective temporal resolution that equals the repetition 
time of the scans.  A schematic diagram of the binning strategy is shown in Figure 5.1. 
The binning method averages data points from all the functional cycles collected at the jth 
time point, and the process is repeated for each time point. The resulting spectra have a 
temporal resolution that equals the repetition time of the pulse sequence. 
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Figure 5.1. Schematic diagram of the binning method for event-related paradigm, where 
the scan consisted of m functional cycles and each functional cycle consisted of n time 
points. tij represents jth data collected after the onset of stimulation during ith functional 
cycle.  
 
5.2.3 Data analysis 
 
     A simulated basis set for use with LCModel for analyzing the data was generated for 
echo-time = 73 ms for the MEGA-PRESS sequence with an editing pulse of 64 Hz 
bandwidth applied at 1.3 ppm, using programs written in C++ using GAMMA tools (17, 
19).  The simulation incorporated ideal slice selective pulses and real editing pulses. FIDs 
from 8000 gradient points were summed to include the effect of crusher gradients on the 
spin resonances in the presence of frequency selective pulses. All the data sets were zero-
filled to 8192 points and an exponential filter of 2 Hz was applied to the time–domain 
signals to reduce the noise.  The resulting spectra were analyzed using LCModel for both 
the studies; block paradigm and event-related paradigm. NAA peaks from the event-
related paradigm with 2 s temporal resolution were analyzed using a custom-built 
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program written in MATLAB and the results grouped as activation and rest to calculate 
average and standard deviation values for peak height, linewidth, and area. 
 
Statistical Methods 
 
     The differences in [met]/[tCr] ratios were estimated using a mixed-effect model for 
data binned in 1 minute blocks for the block paradigm and the data for the event-related 
paradigm using a restricted maximum likelihood (REML) method.  
 
5.2.4 Detection threshold determination 
 
      Theoretical CRLBs for a set of 17 metabolites were calculated using the basis set 
generated for analyzing the data for the study.  CRLB calculations were performed using 
the average metabolite concentrations report in the literature and linewidths and SNR 
typically observed in this study. The CRLBs were used to determine the sensitivity of the 
study to measure changes in metabolite concentrations during regional activation. 
 
 67 
5.3 Results and discussion 
 
5.3.2 Block paradigm 
 
 
Figure 5.2. (Top) Water peak height (blue) and water line widths (red) during activation 
and rest blocks. (Bottom)Water spectra acquired during 3 cycles of 30 seconds of 
activation (red) followed by 30 seconds of rest (blue) showing BOLD response. 
 
     Figure 5.2 shows the increases in peak heights and corresponding decreases in 
linewidths of water spectra during activation that return to baseline during rest.  This is a 
measurement of the BOLD response from the water signal using MRS and confirms the 
accuracy of the voxel placement in the region activated during visual stimulation.  The 
temporal resolution of water-unsuppressed spectra was 3 s and we observed a lag in the 
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beginning of the BOLD response between 6 and 9 s , and between 9 and 12s for the water 
peak height to decrease and linewidth to increase after the end of stimulus. Average 
change in the water peak height and water linewidth during activation were: +2.92% and 
-2.48% respectively.  
 
 
Figure 5.3. In vivo spectra acquired from the visual cortex using MEGA-PRESS 
sequence with editing frequency at -60 Hz and editing pulse bandwidth of 64 Hz. 120 
transients were averaged to generate each spectra at TE/TR = 73/2000 ms. 
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Figure 5.4. LCModel results for Lactate to Creatine ratio for 7 subjects showing increase 
in lactate concentration during stimulus (red) compared to rest (blue) for 6 of the 7 
volunteers. 
 
     Representative spectra are shown in Figure 5.3 which shows the typical signal-to-
noise ratio achieved during the scans in this study. Results from LCModel showing an 
increase in lactate concentration during activation in 6 of the 7 volunteers scanned for this 
paradigm are shown in Figure 5.4. An average change in lactate concentration for 7 
volunteers was 26.3 ± 21.6% consistent with the increases reported in the recent studies 
(48, 52). While analysis of spectra from averaging two 8 minute blocks shows increases 
in lactate for most of the volunteers during the activation period, statistical analysis of 1 
minute blocks did not show significant change in any of the metabolites during block 
stimulus. 
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5.3.2 Event-related paradigm 
a)   
b)  
c)  
Figure 5.5. Results from peak analysis showing a) peak height, b) linewidth, and c) area 
under the NAA peak during activation (red) and rest (blue) for 5 subjects. 
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     Figure 5.5 a, b and c show the increases in peak height, decreases in linewidth and 
non-significant differences in areas of the NAA peak during activation compared to rest 
periods in 5 subjects. These NAA results are consistent with the results reported by Zhu 
et al (51).  We observed between an 8-10 s second delay in the observed increase in the 
NAA peak height after the onset of stimulation consistent with the delay in hemodynamic 
response as well as an 8-10 s delay in the decrease in the NAA peak back to baseline after 
the end of stimulation. The time delays for observance of changes due to BOLD response 
from analysis of water spectra and NAA in this study are comparable. 
 
Figure 5.6. Metabolite time courses with 2 s resolution during activation (red) and rest 
(blue) periods averaged across 5 subjects. 
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     Figure 5.6 show metabolite concentrations as a function of time during periods of 
activation and rest averaged across 5 subjects. Statistical analysis of LCModel results of 
spectra with 2 s temporal resolution shows 5.37% ± 2.32% (p < 0.05) increase in Glu and 
-8.21% ± 3.74% (p < 0.05) decrease in NAAG during activation. Our analysis did not 
correct for any variation in linewidth during the activation period and we did not observe 
a significant change in NAA to Creatine ratios between activation and rest periods. 
 
Figure 5.7. Running average of 5 time points of [lac/tCr] as a function of time from 5 
subjects. Red plot represents [lac/tCr] area during 32 s of activation and blue during 32 s 
of rest. The last 4 points in the plot only consist of data from 1 time point. 
 
     Running averages of 5 time points of [lac/tCr] from LCModel averaged over 5 
subjects show a gradual increase in lactate concentration during activation and can be 
observed in Figure 5.7. An increase in [lac/tCr] was observed in the running average plot 
after 8 s of stimulation.  The increase level of [lac/tCr] persisted until about 14 s after the 
end of stimulation followed by a decrease back to baseline levels. While an increase in 
lactate level was observed in the plot with running average of 5 time points, the results 
were not statistically significant when analyzing individual time points.  
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     The detection limitation of the current experiment based on the theoretical CRLB for 
lactate is 6.32%, glutamate is 2.73% and for NAAG is 2.54%. Given the sensitivity of 
detection in change of lactate concentration of 6.32%, our observation of 26.30% 
increase in lactate during a prolonged stimulation of 8 minute, confirm the increased 
lactate levels during prolonged activation. At shorter time scales of 16 s and 32 s, we did 
not observe increases in lactate levels with statistical significance despite our observation 
of increases in lactate levels from the running average plot suggests the need for a larger 
sample size to reach statistical significance.  
     Our results show that the binning method employed in this study improved the 
temporal resolution of the functional MRS study.  However, despite the use of this novel 
binning method and the short duration of the functional trial, data from individual 
subjects did not contain enough SNR to effectively study changes in metabolite profiles 
during activation.  Datasets from 5 subjects were used to perform the analysis. Given the 
restriction of the scan time on a volunteer, the full benefit of using this binning method 
for fMRS studies will be realized by increasing the number of data sets thereby 
increasing the number of samples per time point. 
 
5.4 Conclusions 
 
     Our results show that the binning method employed in this study is an effective way to 
increase temporal resolution in fMRS measurements. BOLD changes in water spectra and 
NAA peak are observed during activation and provide a robust quality control criteria for 
ensuring acquisition of data from the activated region.  We observed increases in Lactate 
concentrations during prolonged stimulation and as well as during 32 s of stimulation 
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although not with strong statistical significance.  We also observed increases in glutamate 
during 32 s of stimulation and simultaneous decreases in NAAG with statistical 
significance.  To our knowledge, these are the first reported measurements made with 2 s 
temporal resolutions, and increasing the number of samples per time point can help make 
robust measurements on changes in metabolite profile with statistical significance even at 
2 s temporal resolution. 
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CHAPTER VI 
 
 
CONCLUSION 
 
     MRS is a powerful tool for non-invasive measurements of metabolite concentrations 
in the brain.  However, the low SNR of spectra coupled with spectral overlap between 
different metabolites necessitates careful evaluation of the effects of experimental 
parameters while for some metabolites, specialized pulse sequences and data analysis 
techniques must be developed. Material presented in this dissertation is aimed to improve 
measurements and quantification of metabolites, neurotransmitters in particular, through 
different approaches. 
 
6.1 Numerical evaluation of optimal detection parameters 
 
     One of the approaches used for improving metabolite detection is moving to higher 
field strengths.  Increased static magnetic fields result in increased spectral dispersion and 
also increased SNR because the resonance frequency is directly proportional to the static 
magnetic field strength while SNR increases in a more complex manner than depends on 
several factors.  However, the move to higher field strength needs to be accompanied by 
the use of optimal measurement parameters to realize the full benefit of the move and at 
higher fields some technical challenges become more severe. At higher field strength, B0 
and B1 inhomogenieties become increasingly worse, transverse relaxation rates faster and 
the requirement for pulse bandwidth higher. Calculation of theoretical CRLBs for a range 
of parameters of interest is an efficient method of assessing optimal measurement 
parameter values 
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     Chapter 3 of this thesis evaluated the optimal echo-times for detection of 18 
metabolites using PRESS sequence at 7 Tesla using simulated spectra for echo-times in 
the range of 30-180 ms and calculating the theoretical CRLBs at each echo-time.  Our 
results show that while the optimal echo-time for detecting most metabolites is 30 ms, the 
optimal echo-time for glutamate is 109 ms, glutamine is 110 ms, and 2-hg is 96 ms and 
the worst echo-time for making metabolite measurements using PRESS sequence at 7 
Tesla is clustered around 50 ms.  
     Our study evaluated the optimal detection echo-time for making metabolite 
measurements using PRESS sequence at 7 Tesla; however, the CRLB calculation method 
used for this study is very versatile.  CRLB calculations could be performed using the 
methods described in this chapter for any pulse sequence and any set of parameters and 
the results can be used to identify the optimal parameters like pulse sequence, echo-times 
etc with great efficiency.  These CRLB calculations can also be used to test the feasibility 
of a new pulse sequence to detect our metabolite of interest and aid in the implementation 
of methods and parameters that give the highest precision for the metabolite. 
 
6.2 GABA measurements at 3 Tesla and 7 Tesla 
 
     As we move to higher fields, apparent differences in quantification results between 
different field strengths arise and need to be understood. Assessment of the differences 
and the parameters affecting the measurements will help address those issues. 
     Chapter 4 of this thesis reported results from the comparison between GABA 
measurements made at 3 Tesla and 7 Tesla and the requirement for making 
measurements with higher precision at 7 Tesla. Comparison of metabolite measurements 
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made at 3 Tesla and 7 Tesla show large discrepancies in the concentrations.  Increasing 
the bandwidth of the pulses by small amounts mitigated these discrepancies slightly, 
which showed that chemical shift displacement errors due to inadequate bandwidth of the 
slice-selective pulses was one of the main explanations for this discrepancy.  The results 
show that the full benefit of transitioning to higher field strength of 7 Tesla from 3 Tesla 
can only be realized with the use of pulses that are of comparable bandwidth to those 
used at 3 Tesla.  
     For the pulses used for this study, the bandwidth requirement on slice-selective 
refocusing pulses at 7 Tesla to achieve chemical shift displacements equal to that 
observed at 3 Tesla was 5126 Hz.  Given the limitation on maximum B1 that can be used 
at 7 Tesla, specialized pulses with bandwidths higher than 5126 Hz need to be developed 
and implemented to potentially make better metabolite measurements at 7 Tesla 
compared to 3 Tesla. 
 
6.3 Changes in metabolite profile during neuronal activation 
 
     The detection of changes in metabolite concentrations during neuronal activation can 
help understand the coupling between neuronal activity and oxygen metabolism.  Study 
of these concentration changes demand a method that yields a high enough temporal 
resolution to be able detect transient changes with high temporal resolution. Due to the 
low sensitivity of MRS measurements, obtaining data sets with high temporal resolution 
has been elusive with the highest temporal resolution reported in the literature at 20 s.  
     A method of significantly increasing the effective temporal resolution of fMRS 
measurements was presented in Chapter 5 of this thesis. By using an event-related 
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binning method where the data are binned based on the time point after the onset of 
stimulation, a temporal resolution that equals the repetition time of the pulse sequence 
was achieved.  For the experiment presented in Chapter 5, the temporal resolution was 2 
s. However, such high temporal resolution in practice was not possible because of low 
SNR.  Our results showed increase in glutamate and decrease in NAAG during 32 s of 
activation period compared to the 32 s of resting period with statistical significance. 
When grouping the timepoints into 16 s blocks, we observed a gradual decrease in myo-
Inositol during 32 s of activation that gradually increased possibly back to baseline levels, 
after the end of stimulation period with statistical significance. We did not observe any 
change in lactate levels during the 32 s of activation followed by 32 s of rest.  The 
changes we observed with statistical significance were higher than the limitation on the 
precision of our measurement dictated by the CRLB calculations, which indicates these 
observed changes were real. 
     These results were derived from data acquired from 5 volunteers and we were not able 
to observe changes in metabolite concentrations that were statistically significant possibly 
due to the small number of volunteers.  Acquisition of data from a larger number of 
volunteers would help increase the number of samples at each timepoint and evaluate the 
change in metabolites with 2 s temporal resolution and reach a statistical significance on 
the analysis of transient change in metabolite profile during neuronal activation.  
 
6.4 Future directions 
 
     One of the limitations of MRS studies is the low SNR that results in long acquisition 
times.  With the emergence of 7 Tesla, there is potential for achieving higher SNR since 
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it scales linearly with static magnetic field strength.  The cumulative work done as part of 
this thesis will aid in the improvement of the data acquired at 7 Tesla. Application of the 
optimal detection parameters along with high bandwidth pulses at 7 Tesla will help 
acquire data with high SNR and increased spectral resolution. Tailoring the pulse 
sequences and echo-times based on the metabolite of interest, employing pulses with high 
bandwidth will help acquire spectra with higher precision and accuracy at 7 Tesla.  This 
strategy could also be a solution to study metabolite changes during neuronal activation 
more reliably by taking advantage of increased SNR at 7 Tesla.  
     Transient changes in metabolite profile during neuronal activation is of interest and 
based on the results presented on this thesis the following steps should be taken to make 
better measurements at 7 Tesla. Optimal pulse sequence and echo-times at 7 Tesla for 
measuring lac, glc, glu and ins should be investigated using CRLB calculations and the 
pulse sequences implemented at 7 Tesla if not already available and slice-selective pulses 
with high bandwidth should be developed to reduce the chemical shift displacement 
errors.  
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APPENDIX 
 
APPENDIX A. EXAMPLES 
 
Appendix A.1 
 
     Spin systems need to be specified in order to perform density matrix simulations on 
that spin system.  An example of spin system specified for use with GAMMA libraries is 
shown below. 
SysName    (2) : 2spin      - Name of the Spin System 
NSpins     (0) : 2     - Number of Spins in the System 
Iso(0)     (2) : 1H         - Spin Isotope Type 
Iso(1)     (2) : 1H         - Spin Isotope Type 
J(0,1)     (1) : 7.0        - Scalar Coupling (Hz) 
PPM(0)     (1) : 2.00       - Chemical Shift (PPM) 
PPM(1)     (1) : 3.00       - Chemical Shift (PPM) 
Omega      (1) : 128        - 1H Static Field Strength 
 
Appendix A.2 
 
     An example of a program that performs density matrix simulation using ideal pulses 
written in C++ using GAMMA libraries is shown below. 
#include <gamma.h> 
//#include "engine.h" 
//#include <string> 
using namespace std; 
main(int argc, char*argv[]) 
{ 
spin_system sys;            // Declare a spin system 
sys.read(sys_fname+sys_ext);    // Reading the spin system 
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double sw = 10000.;                 // spectral width in hz 
double ppm = sw / sys.Omega();    // setting spectral width                  
NyqF = sw * 2.0;                    // Nyquist frequency 
// acquisition blocks 
block_1D data_Fx(t2pts);           // x-channel acquisition  
block_1D data_Fy(t2pts);           // y-channel acquisition  
gen_op sigma0;     // initial and  working density operator 
gen_op H = Ho(sys);                  // Set up Hamiltonian   gen_op Dx = Fx(sys);  
  // Detect Fx 
gen_op Dy = Fy(sys);            // Detect Fy     
double TE = 0.073;            // Define TE            double tau1 = 0.008;              
 // Define tau1 
double tau2 = TE/2.0-TE1;          // Define tau2            sigma0 = sigma_eq(sys);   
                 // Set the density matrix to equilibrium 
sigmap = Iypuls(sys,sigma0,90.0);// Apply 90 degree pulse  
sigmap = evolve(sigmap,H,tau1);  // Evolve density matrix 
sigmap = Ixpuls(sys,sigmap,180.0);// Apply 180 degree pulse  
sigmap = evolve(sigmap,H,tau1);  // Evolve density matrix 
sigmap = evolve(sigmap,H,tau2);             
sigmap = Ixpuls(sys,sigmap,nsrefo); 
sigmap = evolve(sigmap,H,tau2);  
row_vector t2BLK_Fx = FID(sigmap,Dx,H,1/(sw),t2pts); 
        // FID acquisition 
data_Fx.put_block(step, 0, t2BLK_Fx);    
data_Fy.put_block(step, 0, t2BLK_Fy); 
// Saving Output to Matlab   
MATLAB( out_fname+"_Fx.mat",  "data", data_Fx, 0 );  
MATLAB( out_fname+"_Fy.mat",  "data", data_Fy, 0 );  
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Appendix A.3 
 
An example of a program that performs density matrix simulation using real pulses 
written in C++ using GAMMA libraries is shown below. 
#include <gamma.h> 
//#include "engine.h" 
//#include <string> 
using namespace std; 
main(int argc, char*argv[]) 
{ 
spin_system sys;            // Declare a spin system 
sys.read(sys_fname+sys_ext);    // Reading the spin system 
double sw = 10000.;                 // spectral width in hz 
double ppm = sw / sys.Omega();    // setting spectral width                  
NyqF = sw * 2.0;                    // Nyquist frequency 
// acquisition blocks 
block_1D data_Fx(t2pts);           // x-channel acquisition  
block_1D data_Fy(t2pts);           // y-channel acquisition  
gen_op sigma0;     // initial and  working density operator 
gen_op H = Ho(sys);                  // Set up Hamiltonian   gen_op Dx = Fx(sys);  
  // Detect Fx 
gen_op Dy = Fy(sys);            // Detect Fy     
double TE = 0.073;            // Define TE            double tau1 = 0.008;              
 // Define tau1 
double tau2 = TE/2.0-TE1;          // Define tau2  
double ex_dur = 0.0040;  // excitation pulse duration 
double refo_dur = 0.0060;  // refocusing pulse duration 
double Wrf = -789.0   // Set center frequency 
sigma0 = sigma_eq(sys);   
                 // Set the density matrix to equilibrium 
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matrix ex_wave = MATLAB("spredrex.mat", "a");  
      //Define excitation pulse shape 
matrix refo_wave = MATLAB("gtst1203.mat", "a"); 
      //Define refocusing pulse shape 
row_vector ex_amp(transpose(ex_wave));       
row_vector refo_amp(transpose(refo_wave));   
ex_U = Shxypuls_U(sys,ex_amp,H,sys.symbol(0),Wrf,ex_dur,90.0,90.0); 
      // Set excitation pulse attributes 
sigmap  = evolve(sigma0,ex_U);     // Apply excitation pulse 
sigmap  = evolve(sigmap,H,tau1 – ex_dur/2.0 - refo_dur/2.0);  
        // Evolve density matrix 
refo1_U = Shxypuls_U(sys,refo_amp,H,sys.symbol(0), Wrf, refo_dur, 180.0, 180.0);  
  // Set refocusing pulse attributes 
sigmap  = evolve(sigmap,refo1_U);  // Apply refocusing pulse 
sigmap  = evolve(sigmap,H,tau1 - (refo_dur/2.0));  
        // Evolve density matrix 
sigmap  = evolve(sigmap,H,tau2 - (refo_dur/2.0));  
        // Evolve density matrix 
refo2_U = Shxypuls_U(sys,refo_amp,H,sys.symbol(0),Wrf,refo_dur, 180.0,180.0); 
  // Set refocusing pulse attributes 
sigmap = evolve(sigmap,refo2_U);  // Apply refocusing pulse 
sigmap = evolve(sigmap,H,tau2 - (refo_dur/2.0));  
        // Evolve density matrix 
row_vector t2BLK_Fx = FID(sigmap,Dx,H,1/(sw),t2pts); 
        // FID acquisition 
data_Fx.put_block(step, 0, t2BLK_Fx);    
data_Fy.put_block(step, 0, t2BLK_Fy); 
// Saving Output to Matlab   
MATLAB( out_fname+"_Fx.mat",  "data", data_Fx, 0 );  
MATLAB( out_fname+"_Fy.mat",  "data", data_Fy, 0 );  
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Appendix A.4 
 
     An example of a makebasis.IN file is shown below. 
$SEQPAR 
 echot=73. 
 seq='PRESS' 
 fwhmba=0.01 
 $END 
 
 $NMALL 
 HZPPPM=298.000000 
 DELTAT=0.0001000 
 NUNFIL=16384 
 FILBAS='.lcmodel/simulation/output/JDIFF_GABA_7T.basis'  
 FILPS='.lcmodel/simulation/output/JDIFF_GABA_7T.ps'  
 AUTOSC=.false.  
 AUTOPH=.false. 
 IDBASI='MEGA-PRESS GABA simulated basis set' 
 $END 
 
 $NMEACH 
 FILRAW='.lcmodel/simulation/raw/jdiff_7T/asp.RAW' 
 METABO= 'Asp' 
 DEGZER = 0. 
 DEGPPM = 0. 
 CONC=0.1 
 CONCSC=100. 
 PPMAPP=0., -.04 
 $END 
 
 $NMEACH 
 FILRAW='.lcmodel/simulation/raw/jdiff_7T/gaba.RAW' 
 METABO= 'GABA' 
 DEGZER = 0. 
 DEGPPM = 0. 
 CONC=0.1 
 CONCSC=100. 
 PPMAPP=0., -.04 
 $END 
 
 $NMEACH 
 FILRAW='.lcmodel/simulation/raw/jdiff_7T/gln.RAW' 
 METABO= 'Gln' 
 DEGZER = 0. 
 DEGPPM = 0. 
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 CONC=0.1 
 CONCSC=100. 
 PPMAPP=0., -.04 
 $END 
 
 $NMEACH 
 FILRAW='.lcmodel/simulation/raw/jdiff_7T/glu.RAW' 
 METABO= 'Glu' 
 DEGZER = 0. 
 DEGPPM = 0. 
 CONC=0.1 
 CONCSC=100. 
 PPMAPP=0., -.04 
 $END 
 
 $NMEACH 
 FILRAW='.lcmodel/simulation/raw/jdiff_7T/gsh.RAW' 
 METABO= 'Gsh' 
 DEGZER = 0. 
 DEGPPM = 0. 
 CONC=0.1 
 CONCSC=100. 
 PPMAPP=0., -.04 
 $END 
 
 $NMEACH 
 FILRAW='.lcmodel/simulation/raw/jdiff_7T/naa.RAW' 
 METABO= 'NAA' 
 DEGZER = 0. 
 DEGPPM = 0. 
 CONC=0.1 
 CONCSC=100. 
 PPMAPP=0., -.04 
 $END 
 
 $NMEACH 
 FILRAW='.lcmodel/simulation/raw/jdiff_7T/naag.RAW' 
 METABO= 'NAAG' 
 DEGZER = 0. 
 DEGPPM = 0. 
 CONC=0.1 
 CONCSC=100. 
 PPMAPP=0., -.04 
 $END
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APPENDIX B. SUPPLEMENTARY MATERIAL 
 
Appendix B.1 
 
Concentration and corresponding CRLB measurements for a set of 17 metabolites in 
Chapter 3. 
TE 
(ms) Ala Asp Cre GABA Glc Gln Glu GPC Gsh Lac Ins NAA NAAG PCh PCr Scyllo Tau 
Conc. 
(mM) 1.2 1.2 8.0 1.5 1.0 4.5 10.0 1.0 2.0 1.0 6.5 15.0 2.0 2.0 4.0 0.5 1.2 
T2 = 109 ms 
30 6.7 18.5 1.2 11.1 14.3 7.6 2.5 6.1 3.5 8.3 1.2 0.3 2.2 3.1 2.4 4.8 8.9 
109 8.4 28.6 2.6 9.1 33.8 4.1 1.7 12.1 4.9 10.3 3.4 0.7 4.6 6.1 5.1 9.8 14.8 
T2 = 158 ms 
30 6.2 17.0 1.1 10.2 13.1 7.0 2.3 5.6 3.2 7.6 1.1 0.3 2.0 2.8 2.2 4.4 8.2 
109 6.1 21.0 1.9 6.6 24.8 3.0 1.2 8.9 3.6 7.5 2.5 0.5 3.3 4.5 3.7 7.2 10.9 
 
Appendix B.2 
 
     Dependence of metabolite CRLBs on echo-time for T2 = 109 ms for a set of 17 
metabolites calculated for echo-times in the range of 30-150 ms with concentrations 
shown in Appendix B.1 is shown below. 
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